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(iii) 
FORET'!ORD. 
The enzyme converting chorismate (I) to 
4-hydroxybenzoate (II) and pyruvate (III) has not 
been previously named. The two mechanistic schemes 
shown below indicate that in each case the C-0 bond 
is broken thus releasing a pyruvate moiety. 
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(iv) 
An enzyme which is capable of splitting a C-0 bond is 
called a lyase . This is in agreement with the Report of the 
Commission on Enzymes of the International Union of nio-
che~istry (1961) which states that:-
' Enzymes removing qrouos from substrates 
non - hydrolytically, leaving double honds 
(or adding groups to double bonds) will 
be called "lyases" in the systematic nom-
enclature . ' 
The sub-group into which the enzvme carryina out this 
reaction could best be placed, is the keto-acid lyase group. 
The argument for placing it in this sub-arouo is based on 
the mechanistic scheme for citrate lyase as shown below. 
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(v) 
It is seen that the hyrtroxyl group of citrRte (I) is 
deprotonated and this unstable situation yields the more 
stable ketone thus breakinq the C-C bond to form oxaloacetate 
(II) and acetate (III). Fro~ this reaction mechanism, the 
systematic name given to the enzyme is citrate oxaloacetate 
lyase, since a ketone group is formed as a result of the 
hydroxyl group beinq deprotonated. 
Similarly, this enzyr:1e procuces a keto-acict, pyruvate . 
On thls reasoning, therefore, the enzymP has been qiven the 
systematic name of chorismate nyruvate lyase. The trivial 
name su0qested for this enzyme is ' chorismate lyase', which 
name will be used in this thesis. 
(vi) 
ABBREVIATIONS. 
Throughout this thesis, each Figure and Table is 
presented on a separate page and follows the page of the 
text on which the first reference to it has been made. 
The following abbreviations have been used:-
Dansyl 
HEPES 
TES 
TEA 
5-Dimethylamino-naphthalene sulphonyl 
J 
N-2Hydroxyethylpiperazine-N -2-
ethanesulphonic acid. 
N~Tris(hydroxymethyl)methyl-2-amino 
ethane sulphonic acid. 
Triethanolamine 
(vii) 
SUMMARY. 
Chorismate lyase was purified to homogeneity from 
extracts of Escherichia coli, AN58. The purification of 
the enzyme was carried out as it was of interest to 
determine if this vitamin enzyme involved in the biosyn-
thesis of ubiquinone, a well"""known respiratory compound, 
was present in the cell in normal amounts and/or possessed 
a high or low turnover number. 
The genetic and biochemical aspects of a mutant strain 
of~- coli which lacked the ability to form 4-hydroxy-
b e nzoate was investigated and it was found that the gene 
which coded for chorismate lyase was probably the 
structural gene. Regulation of chorismate lyase activity 
in whole cells indicated that ubiquinone did not affect 
the level of activity whereas other indications suggested 
that 2-octaprenyl-phenol or an earlier biosynthetic 
intermediate could repress the level of chorismate lyase. 
The protein was shown to be homogeneous by several 
criteria. Sedimentation velocity experiments were 
carried out and results showed the presence of only one 
symmetrical peak. Polyacrylamide gel electrophoresis of 
the enzyme in the presence of 0.1% sodium dodecyl sulphate 
yielded only a single polypeptide chain. The molecular 
weight was determined by two methods, namely by equilibrium 
(viii) 
sedimentation experiments and by gel filtration and the 
results from gel filtration experiments indicated a 
molecular weight of 15,800. Fingerprints of tryptic 
peptides obtained from digests of chorismate lyase 
indicated that the enzyme contained 14-18 peptides which 
is a little higher than the range predicted from the 
amino acid composi~ion, for a protein with a molecular 
weight of 15,800. Reasons are given why this aspect 
of the work requires further investigation. 
General kinetic properties of chorismate were studied 
and the results indicated that, the Km for the reaction 
I 
was high while the Ki . for 4-hydroxybenzoate was very 
low. Results showed that low concentrations of 4-hydroxy-
benzoate could competitively in~ieit the reaction. Other 
, . I • 
compounds which were structurally similar to either the 
substrate o·r product of the reaction were tested for 
their affect on the reaction. Allosteric modifiers and 
various chemical reagents were also tested for their 
effect. 
Difficulty has been incurred in the prepartion of this 
enzyme due to (i) the low levels of activity in ·cell-free 
extracts (ii) the effects observed on concentrating 
protein solutions and (iii) the effects of using high 
and low ionic strength buffer. The complex behaviour of 
chorismate lyase was eventually understood and further 
(ix) 
investigations of its properties were carried out. The 
enzyme was eventually shown to possess an extremely low 
turnover number which is to be expected because it is a 
·vitamin enzyme. 
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SECTION 1. GENERAL INTRODUCTION. 
1. 
The shikimate pathway for the biosynthesis of aromatic 
compounds was elucidated by several groups of workers, as 
exemplified by Davis (1955), Sprinson J1960), and Gibson and 
Gibson (1964). The general outlines of the pathways to the 
aromatic amino acids, phenylalanine, tyrosine, and tryptophan 
have been known for some time and have been reviewed by 
Umbarger and Davis (1962) and Gibson and Pittard (1968) · 
The original discovery ot 4-hydroxybenzoate as a bacterial 
vitamin was first shown by Davis (1950). 
Mutants of Esoher•ichia coli were isolated by Davis (1950) 
and found to respond to the four supplements, tyrosine, 
phenylalanine, tryptophan and 4-aminobenzoate. Such mutants 
were called multiple aromati~ auxotrophs since the metabolic 
block occurred in the common pathway. The quantitative 
requirements for the three amino acids were similar to those 
mutants with single requirements for these compounds. However, 
growth was very slow with low concentrations of 4-aminobenzoate 
(0.005 µg per ml), although this concentration was sufficient 
for optimal growth of a mutant blocked specifically in 
4-aminobenzoate synthesis. Higher concentrations of 
4-aminobenzoate (up to 1 µg per ml) provided more rapid, ye t 
less than normal growth of the mutant. It was shown that 
normal growth-rate was obtained when shikimate, a known 
precursor ' of the· above four metabolites, was included in the 
medium. It was therefore postulated by Davis (1950) that 
another compound, which could readily be formed from shikimate, 
2. 
was responsible for recovery of normal growth. The compound 
was subseqµently shown to be 4-hydroxybenzoate and a concen-
tration as low as 0.01 µg per ml supported rapid growth in 
the presence of the other four supplements. The high order 
of activity shown by 4-hydroxybenzoate led Davis to conclude 
that this compound should be considered a bacterial vitamin. 
4-Hydroxybenzoate, like 4-aminobenzoate, was found in signif-
icant concentrations in yeast autolysate, in filtrates from 
culture~ of wild type b~cteria but not in liver extract. 
(It was also shown by Davis (1950) that 4-hydroxybenzoate 
is present in Whatman No. 1 chromatography paper.) 
Davis (1952) subsequently showed that the requirement for 
4-hydroxybenzoate as a growth factor was not an absolute one. 
Mutants of E.coli, Aerobacter aerogenes, Salmonella typhim-
urium, and Baeillus subtilis, that required two, three, four 
or five aromatic compounds, were shown to be blocked in the 
synthesis of those precursors that are common to all five of 
the compounds. The more complete the block, the greater the 
number of growth requirements needed; an increasing inability 
to synthesize the common precursors leads to successive 
growth requirements in the following order: tyrosine, phenyl-
alanine, tryptophan, 4-aminobenzoate and finally, 
4-hydroxybenzoate. 
Briefly discussing the various biosynthetic pathways, 
the common pathway involves the condensation of two products 
of carbohydrate metabolism, phosphoenolpyruvate and erythrose-
4-phosphate, to give a straight chain seven carbon compound 
3. 
(Figure 1.1). This compound is then cyclized and undergoes 
a series of reactions through shikimate to chorismate. 
Before 1964, little was known about the branch-point compound. 
It was known, however, that 3-enolpyruvylshikimate-5-phosphate 
was an intermediate in the common pathway (Levin and Sprinson, 
1960, 1964) and that this compound gave rise to three other 
compounds involved with aromatic biosynthesis, namely anthran-
ilate, phenylpyruvate, and 4-hydroxyphenylpyruvate (Gibson et 
al. 1962; Rivera and Srinivasan, 1962). With the isolation 
and identification of chorismate (Gibson and Gibson, 1962, 
1964; Gibson, 1964), the branch-point compound from which all 
other aromatic pathways diverged was established. 
The isolation of chorismate was achieved by using a triple 
mutant of A. aerogenes 62-1 in which tryptophan, and tyrosine 
were essential growth factors, and phenylalanine stimulated 
growth. Cell-free extracts of this strain were shown to form 
chorismate from a mixture of shikimate, ribose-5-phosphate, 
2+ NADH, ATP and Mg . Cell-free extracts of a multiple aromatic 
auxotroph A. aerogenes 170-44 with a metabolic block 
immediately after 3-enolpyruvylshikimate-5-phosphate, could 
not only enzymically convert chorismate to anthranilate, 
(in the presence of glutamine} but also convert chorismate 
to prephenate (and so to phenylpyruvate and 4-hydroxyphenyl -
pyruvate), 4-aminobenzoate and 4-h_ydroxybenzoate (Gibson 
and Gibson 1962, 1964; Gibson, 1964; Gibson et al. 1964). 
FIGURE 1. 1 General outlines of nathways for the formation of aromatic 
amino acids and vitamins in E. coli. 
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Since this time the region around the branch-point 
compound has been further clarified by many workers. Choris-
mate has been isolated from culture fluids of a variety of 
" 
organisms e.g. E. coli (Lingens and Muller, 1967), Neurospora 
crassa (DeMoss, 1965), Saccharomyces cerevisiae (Lingens and 
II 
Muller, 1967) ' and has been shown to be metapolized by cell 
extracts from Lactobacil-ius arabinpsus (Lingens et al. 1967a) , 
N. crassa (DeMoss, 1965), Claviceps paspali (Lingens et al. 
1967b) , S. cerevisiae (Doy and Cooper, ·1966; Lingens et al., 
1966) and plants (Cotton and Gibson, 1968). 
These reactions from the branch-·point compound pointed the 
way to investigatiohs of other possible derivatives arising 
from chorismate. Young et al. (1967a)showed that cell-free 
extracts of A. aerogenes 62-1 converted chorismate to 
2,3 dihydro-2,3-dihydroxybenzoate which, in the presence of 
2+ NAD,Mg , served as a source of 2,3 dihydroxybenzoate (Young, 
Jackman and Gibson, 1967 b) ~ An earlier int'ermediate in the 
sequence of 2,3 dihydroxybenzoate formation was isolated and 
identified by Young et al. (1969). Cell-free extracts of 
A. aerogenes 62-1 were fractionated by chromatography on 
DEAE·-cellulose and a fraction was obtained which could con-
vert chorismate to a new intermediate, capable of being 
converted to 2,3-dihydro-2,3-dihydroxybenzoate. This compound 
was given the trivial name of isochorismic acid (Young et 
al. 1969). 
Subsequently, Brot and Goodwin (1968) isolated an enzyme 
from extracts of a methionine-vitamin B12 auxotroph of 
E. coli K-12 which catalyzed the synthesis of 2,3-dihydroxy-
benzoyls erine from 2,3-dihydroxybenzoate and L-serine in the 
presence of ATP. The enzymic activity only appeared during 
the latter stages of growth and could not be detected when 
the organism was grown in a glucose, methionine salts medium 
containing Feso 4 . The appearance of enzymatic activity from 
cells t hat were grown in the presence of iron, was dependent 
upon the p resence of a chelating agent and the de novo 
synthesis o f protein. Further, 2,3-dihydroxy-N-benzoylserine 
has been isolated and identified in E. coli by O' Brien et al. 
(1969 ). Th e end product of the pathway in E. coli involving 
2,3-di hydroxybenzoate has been identified by O'Brien and 
Gibson (1 9 70 ) as a cyclic derivative of 2,3 dihydroxybenzoate, 
and has been named enterochelin. A similar compound has been 
isolated in Salmonella typhimurium by Pollack and Neilands 
(19 70 ) and called enterobactin. Both enterobactin and 
enterochelin are iron sequestering agents. 
5 
Apart from chorismate being metabolized along the various 
pathways (Figure 1.1), it is unstable under physiologica l 
conditi ons. Gibson (1964), and Gibson and Gibson (1964) showed 
that chori s ma te under these conditions decomposes to a mixture 
of compounds, namely 4-hydroxybenzoate and prephenate, the 
latter compound giving phenylpyruvate in acid solu~ion. 
6. 
Before 1964, little was known of the biosynthetic origin 
of ubiquinone and menaquinc~e. The initial observation of 
14 Rudney and Parson (1963) that C-labelled 4-hydroxybenzalde-
hyde was incorporated into the benzoquinone ring of ubiquinone 
in the photosynthetic bacterium, Rhodospirillum rubrum, 
established the first possible intermediate in the biosynthesis 
of ubiquinone. Later, Parson and Rudney (1964) showed that 
14 C-4-hydroxybenzoate, as well as the aldehyde were able to be 
incorporated into ubiquinone in Azotobacter vinelandii, 
Baker's yeast and rat kidney. These two compounds were also 
shown to be incorporated into R. rubrum (Parson and Rudney 
1965). 
Since this time, the number of organisms which are known 
to incorporate 4-hydroxybenzoate into ubiquinone has increased. 
Cox and Gibson (1964) found that 4-hydroxybenzoate and 
shikimate were incorporated into ubiquinone in E. coli. 
Multiple aromatic auxotrophs of E.coli, when grown on a 
--
glucose mineral salts medium supplemented with the aromatic 
amino acids and 4-aminobenzoate, only formed ubiquinone when 
4-hydroxybenzoate was present (Cox and Gibson 1966). However, 
in similar experiments with A. aerogenes, ubiquinone was 
formed in the absence of 4-hydroxybenzoate, suggesting that an 
alternative pathway to ubiquinone could exist in these cells. 
The results of experiments with cell-free extracts of A. 
aerogenes indicated that 4-hydroxybenzoate was formed from 
tyrosine (Cox and Gibson, 1966), (Figure 1.2). Although 
4-hydroxyphenylpyruvate may be spontaneously converted to 
PHENYLALANINE 
-----•--• CHORISMATE • PREPHENATE 
FIGURE 1.2 
4-HYDROXYPHENYLPYRUVATE TYROSINE 
I 
' 4-HYDROXYBENZALDEHYDE 
4- HYDROXYBENZOATE 
UB IQUINONE - 8 
Outline of probable pathways of the b i osynthesis of 4-hydroxybenzoate 
in E.coli and A. aerogenes. The broken line represents a pathway 
that has not been confirmed by experiments with cell-free extracts. 
E. coli could not convert 4-hydroxybenzaldehyde into 4-hydroxy-
benzoate. Taken from Cox and Gibson (1966). 
7 • 
4-hydroxybenzaldehyde at physiological pH, no enzyme has been 
found to carry out this conversion. Miller (1965) showed 
that 4-hydroxybenzoate was a direct precursor of the benzo-
quinone ring of ubiquinone in Tetrahymena pyriformis while 
Whistance et al. (1966) have found 4-hydroxybenzoate was 
incorporated into ubiquinone in higher plant tissue. 
Since chorismate was established as the branch-point 
compound for the biosynthesis of aromatic compounds in bacteria, 
it was only a short time before the aromatic nucleus of ubi-
quinone was established as being derived from the common path-
way and chorismate. Cox and Gibson (1964) showed that when the 
gram-negative facultative anaerobe, E.coli, was grown in the 
presence of D-/ G-14cJ shikimate, radioactivity was incorpor-
ated into both ubiquinone-8 and menaquinone-8. 4-Hydroxyben-
zoate diluted the incorporation of shikimate into ubiquinone 
but had no effect on menaquinone biosynthesis. On the other 
hand, 3,4-dihydroxybenzaldehyde diluted the incorporation of 
labelled shikimate into menaquinone without affecting the 
level of radioactivity in ubiquinone (Cox and Gibson, 1966). 
Although the isotope competition effect has been confirmed by 
Leistner (1967), 14c and 3H labelled 3,4-dihydroxybenzaldehyde 
is not incorporated into the menaquinones of A. aerogenes, 
Bacillus megaterium, E. coli and Proteus vul·garis (Campbell 
et al. 1967; Leistner et al. 1967 -; -GuE{rin et al. 1970). 
On studying the biosynthesis of menaquinone, Cox and 
Gibson (1966) found that multiple aromatic auxotrophs of 
8 . 
A. aerogenes blocked between 3-enolpyruvylshikimate-5-phosphate 
-
and chorismate were unable to synthesize menaquinone _or ubi-
quinone. A possible precursor .in the biosynthesis of menaquin-
one was suggested by Leistner et al. (1967) who showed that 
14c- a -naphthol was ,incorporated into menaquinone. Since then 
experiments have been reported which show that radio-activity 
from a ;-1 - 14cJ naphthol is incorporated into menaquinones by 
the Gram-positive bacterium Staphylococcus aureus and the Gram-
,,. 
negative ~bacterium ~- aerogenes (Guerin et al~ 1970; Hammond 
and White, 1969), o~t not the Gram..:.positive bacteria 
B. megaterium, B. subtilis, Micrococcus lysodeikticus, 
Mycobacterium phlei and the Gram-negative bacteria~- coli, 
Proteus mirabilis and P. vulgaris (Brown et al., 1968; Ellis 
and Glover, 1968; Guerin et ~1-. _ 1970) ... - These anomalous 
results were explained by Threlfall (1971) who stated that 
~ --naphthol was an abnormal precursor and that those organisms 
which could utiiize it possessed the necess~ry enzyme to convert 
it to 1,4 naphthoquinol. 
' More recently Dansette and Azerad (1970) have pr~posed a 
scheme for the biosynthesis of menaquinone. This involves 
the condensation, coupled with the dehydration of chorismate, 
of a c 4 derivative of glutamate followed by a simple elimi n -
ation reaction to form C-succinyl benzoate. A more favoure d 
hypothesis is the attack of the same c 4 derivative on 
isochorismate. To support their proposals, Dansette and 
Azerad (1970) showed that when multiple aromatic auxotrophs 
of E. coli, blocked in the early steps of aromatic biosyn-
9. 
thesis, were grown on a aromatic supplement and O-succinyl-
benzoate, the same amount of menaquinone-8 was formed as 
when the same auxotrophs were grown in the presence of 
shikimate. When a mutant strain of E.coli was blocked after 
shikimate, only O-succinylbenzoate was effective. Finally, 
these workers synthesized O-succinyl L-carboxy-14c 7 benzoic 
acid and showed that the radio-activity was incorporated into 
menaquinone-9 by~- phlei, demethylmenaquinone-8 and menaquin-
one-8 by A. aerogenes and E. coli, and a number of other 
plants. Dansette and Azerad (1970) proposed that O-succinyl-
benzoate was cyclized to form 1,4-dihydroxy-2-naphthoate, the 
first napthalenic compound on the pathway and this was then 
decarboxylated to give 1,5 naphthoquinol. Other than these 
lines of evidence nothing more is known about the biosynthesis 
of menaquinone. 
A pathway for the complete biosynthesis of ubiquinone has 
been proposed in E. coli by Friis et al. (1966) and is shown 
in Figure 1.3. However, at the time that the present work was 
commenced, only a few of the compounds proposed in this scheme 
had been isolated and fully characterized. There have been 
two main approaches used to isolate and identify intermed-
iates in the pathways leading to the biosynthesis of ubig in-
ane. One approach that has been taken by several groups o f 
workers is that in normal cells, small quantities of bio-
synthetic intermediates may be present (Olsen et al. , 1966; 
Imamoto and Senoh, 1967; Whistance, Brown and Threlfall, 1969; 
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FIGURE 1.3 
X 
The possible pathway of ubiquinone biosynthesis 
in E. coli showing the positions of the ubi genes 
and the reactions which are affected by these 
mutations. The broken lines represent reactions 
that have not been confirmed by experiments with 
cell-free extracts . The compounds are · 
I. chorismate; II. 4-hydroxybenzoate; 
III. 4-hydroxy -3-octaprenvlbenzoate; 
I 
IV. 2-octaore nylohe nol; V. 6-hydroxy-2-octaprenyl-
phenol ; VI . 6-methoxy-2-octaprenylphenol ; 
VII. 6-methoxy-2-octaprenyl-1,4-benzoouinone; 
VIII . 6-methoxy-3-methyl-2-octaprenyl-1,4-benzo-
quinone; IX . 5-hydroxy-6-methoxy-3-rnethyl-2-octa-
prenyl-1 ,4-benzoquinone ; X. ubiauinone. 
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Friis et al., 1967). Therefore, possible intermediates in 
ubiquinone biosynthesis may be isolated and identified 
after extraction of large quantities of normal cells. This 
approach has also been used in conjunction with labelled 
precursors of ubiquinone, for example, labelled 4-hydroxy-
benzoate. The second approach has been to isolate mutants 
which are unable to form ubiquinone. In other metabolic 
pathways it has usually been found that biosynthetic inter-
mediates immediately preceding a metabolic block often accumu-
late and may then be isolated, identified. and used in cell-
free systems tp confirm the pathway and to study the 
individual reactions. 
Cox et al., (1968) isolated mutant strains of E. coli 
K-12 unable to form ubiquinone , using a technique involving 
an indirect selection procedure. It was assumed that ubi-
quinone was an essential component in the electron-transport 
chain between certain oxidizable substrates and molecular 
oxygen. The utilization of compounds, such as malate or 
succinate, as sole source of carbon must rely on hydrogen 
transfer to oxygen for the cell to obtain energy and inter-
mediates for biosynthesis (a discussion of the role of ubi-
quinone in electron transport is given later). On the o ther 
hand a strain lacking ubiquinone should grow with glucose 
as sole source of carbon because E.coli is a facultative 
anaerobe and can grow by fermentative mechanisms. Therefore, 
ubiquinone-deficient strains of E. coli were selected for 
their ability to grow fermentatively on glucose, and for 
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their inability to grow on a reduced substrate such as 
malate or succinate as sole source of carbon. A number of 
ubiquinone mutants have now been isolated by the above pro-
cedure and genetically and biochemically characterized 
(Cox, Gibson and Pittard, 1968; Cox, Young et al., 1969; 
Young et al., 1971; Stroobant et al., 1972; Young, et al .. 
1972). The reactions which are affected by the ubiA, ubiB, 
ubiD, ubiE and ubiF ubiG and ~biH mutations are shown in the 
I 
proposed scheme. At the commencement of this study only 
one of the reactions had been studied in cell-free extracts 
of~- aerogenes and this was the conversion of chorismate 
to 4-hydroxybenzoate (Gibson and Gibson, 1962, 1964). 
At this point, it is convenient to discuss the 
quinones, ubiquinone and menaquinone, as the function of 
these compounds is important and leads to an understanding 
of what happens when these compounds are absen in ubiquinone-
deficient mutants. Ubiquinone, previously called coenzyme 
Q, was first isolated from one of a number of lipid fractions 
of horse intestine mucosa,' (Festenstein et al. 1955). One 
of these lipid fractions yielded an absorption maxima at 
272 nm in cyclohexane. Morton (1956) and Crane et al. (1 957 ) 
also isolated a compound having similar properties to the 
lipid fraction of Festenstein and coworkers. Crane et al. 
(1957) recognized the quinonoid properties of this com-
pound and therefore its possible involvement as an oxido-
reduction compound in the respiration process. The correct 
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complete structure was not established until 1958 by several 
groups of workers, namely Fahmy et al. (1958), Lester et al. 
(1958) and Wolf et al. (1958). 
Ubiquinone is a 2,3 dimethoxy-5-methyl-l,4 benzoquinone 
with an isoprenoid side chain of varying length. The number 
of isoprenyl units is indicated e.g. ubiquinone-8 in E. coli 
(Figure 1.4). One type of ubiquinone usually predominates in 
a particular species, al though other homologues ''may be 
present. Ubiquinone has been shown to occur in plants, 
animals and microorganisms (Lester and Crane,1959). The 
most common, naturally occurring ubiquinone in higher animals 
and plants, is ubiquinone-10 which has ten . isoprenoid units. 
Other members of the group have side chains varying from six 
to nine isoprenoid units (Crane and Sun, 1972). Ubiquinone 
is found in varying quantities in cells from different organ-
isms. Lester and Crane (1959) collected data on the concen-
tration of ubiquinone from a large number of animals, plants 
and microorganisms and generally concluded that the amount 
of ubiquinone present could be correlated with the respirat-
.• 
ory capacity of the tissue or organism in question, e.g. 
cardiac tissue was always found to contain more ubiquinone 
than skeletal muscle which 1s in keeping with the higher 
respiratory rates of the cardiac tissue. 
The function of the quinones in electron transport has 
been reviewed in several articles (Chance, 1965; Redfearn, 
II 
1966; Crane and Low, 1966; Kroger and Klingenberg, 1967; 
Crane, 1968; and Crane and Sun, 1972). The approaches 
FIGURE 1.4 
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Structure of URIQUINONE-8 and 
MENAQUINONE-8 found in E. coli. 
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taken to investigate and provide evidence for the role of 
ubiquinone in electron transport include:-
II 
(a) the requirement for ubiquinone in the 
respiration of electron transport particles 
that have been deprived of ubiguinone. 
(b) the isolation of enzyme complexes involved 
with the respiration process and partic-
ularly those which catalyse the oxidation 
and reduction of ubiquinone. 
(c} the oxidation and reduction by mitochondrial 
particles of ubiquinone that has been 
extracted and isolated from the same 
particles. 
(d) the oxidation and reduction changes of ubi-
quinone in mitochondria under the influence 
of various substrates, oxygen and inhibitors. 
Kroger and Klingenberg (1967) have made extensive studies of 
the redox potentials of the respiratory carriers in the 
aerobic state and concluded that ubiquinone functions between 
the flavoproteins and the cytochromes. A diagram of the 
currently accepted sequence of electron transport carri e rs 
in mitochondria is shown in Figure 1.5, together with the 
sites of some of the better known respiratory inhibitors. 
NADH dehydrogenase 
system 
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I 
I 
I 
Rote'none 
I 
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Q pool 
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acetone 
FIGURE 1.5 Schematic representation of the sequence of electron transfer in 
mitochondria, showinq the three sites of ~hosphorylation and the 
sites of action of some respiratory inhibitors. 
Taken from Klingenberg (1968) and Crane (1968). 
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Ubiquinone and menaquinone are structurally related 
(Figure 1.4), in that both compounds possess a quinone 
ring to which is a t tached a long isoprenoid chain of varying 
length . Although menaqu inone was discovered some twenty 
years before ubiquinone, more is known about the biosynthes i s 
of the latter compound. The terminology for the vitamins K 
was determined by the IUPAC-IUB Commission on Biochemical 
Nomenclature with vitamin K2 to be referred to as menaquinone 
and vitamin K1 as phylloquinone . It was the original 
discovery of Dam (1935 a,b) of a coagulation· factor in 
chicke ns on fat-free diets that led to the discovery of 
vitamin K. Later, McKee et al. (1939a) discovered two types 
of vitamin K, namely vitamin K1 and vitamin K2 . Vitamin K1 , 
or phylloquinone, was shown to occur in alfalfa (Binkley e t 
al. 1939; Dam et al. 1939; Karrer and Geiger, 1939), while 
putrefied fish meal yielded vitamin K2 or menaquinone . 
Since then, many var ieties within each of these two t ypes 
of vitamin K have been found to occur naturally. The vitamins 
Kare found in animals, plants and microorganisms but they 
probably do not all have the same function. The fi rst rep-
resentative of the menaquinone series was isolated f r om 
putrefied fish meal by McKee et al. (1939b), and shown b_r 
Binkley et al. (1940) to be 2~methyl-l,4-naphthoquinone with 
a long isoprenoid chain. The exact number of isopr enoi d 
units was established as seven by Isler et al. (1958) . 
Menaquinone, like ubiquinone, also has a n isoprenoid side -
chain which varies in length, usually with one form of the 
series predominating in any one spec i es. 
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The antihaemorrhagic properties of vitamin K2 in animals 
have long been known to be associated with the synthesis of 
prothrombin in the liver. However, in thos-e organisms that 
are able to produce vitamin K2 and yet do not possess a 
liver, it is therefore concomitant to say that vibamin K2 
cannot be involved in prothrombin formation. Therefore it 
must have some otner function. Martius (1966) has suggested 
that in the cell metabolism of all organisms, vitamin K2 
must have a specific function similar to other vitamins, 
since lower animals also require the vitamin (Martius et al. 
1965). These authors have shown that several invertebrates, 
such as earthworm, snail and some insects, are able to con-
vert menadione into vitamin K2 . These facts suggest that 
there is a basic role for menaquinone in cell metabolism. 
Quinones in bacteria have been shown to be localized in 
the sub-cellular structures, namely in the cytoplasmic 
membrane (Mitchell and Moyle, 1956; Weibull and Bergstrom, 
1958) and these subcellular structures are known to be in-
volved in biological processes of oxidation and reduction 
(Brodie, 1957; Brodie et al., 1958; Bishop et al.J 1962; 
Baum and Dolin, 1963; White, 1965i Kr~ger and Dadak, 1969) . 
The fact that quinones are found on fractionation of the cells 
in the membrane fraction, together with membrane-bound c y to-
chromes, suggested that the quinones may serve as electron 
carriers in electron transport (Bishop and King, 1962; 
Smith, 1968; Kroger and Dadak, 1969). 
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Morton (1961) has also produced data on the distribution 
of ubiquinone and menaquinone in microorganisms and showed 
that both quinones are implicated in aerobic respiration. 
In agreement with this data, Rudney and Sugimura (1961) 
showed that when yeast cells were grown under anaerobic con-
ditions, ubiquinone-6 was found to occur in smaller amounts 
than when grown aerobically. On aerating anaerobically 
grown yeast in a glucose phosphate medium, the ubiquinone 
content increased five to ten fold. Bishop et al. (1962) 
have shown that most of the aerobic bacteria contain either 
ubiquinone or menaquinone, or both. Gram-positive organisms 
contain menaquinone only, while gram-negative organisms are 
of two_ types, those containing ubiquinone and those contain-
ing both ubiquinone and menaquinone. 
Table l shows some of the respiratory components of the 
membranes in various types of bacteria and these are com-
pared with those of the mitochondrial membrane. On a 
protein basis, the level of the quinones and cytochrome b, as 
well as the NADH-oxidase activities in the bacterial strains , 
are of the same order of magnitude as those of the mito-
chondria from beef heart (Table 1). This indicates the 
functional similarity with respect to the respiration o f the 
bacterial cytoplasmic membrane and the mitochondrial 
membranes. 
Although E. coli has both ubiquinone and menaquinone, 
Bishop et al. (1962) demonstrated that the menaquinone content 
did not vary when E.coli was grown either aerobically or 
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TABLE 1. 
* CONTENTS OF RESPIRATORY COMPONENTS IN MEMBRANES 
Source Ubiquin- Menaquin-
one one 
(µmoles/g protein) 
Mitochondria 6 0 
beef heart 
Micrococcus 1.5 0 
dehitrif-
icans 
(NCIB 8944) 
B.megaterium 0 5.4 
(ATCC 14581) 
Proteus 5.4 3.4 
, rettgeri 
E. coli 4.7 0.67 
Cyto- NADH-oxidase 
chrome b activity 
0.9 
0.18 
0.87 
0.46 
0.19 
( µatoms O per 
min/g pro-€ein) 
850 
570 
985 
657 
560 
It 
* Taken from Kroger and Klingenberg (1970) and 
Cox et al. ( 19 7 0) . 
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anaerobically. This is in contrast to the work of Polglase 
et al., (1966) who showed that menaquinone is present only in 
small amounts in!• co~i when the cells are grown aero-
oically and rises to higher levels during anaerobic growth. 
This is in agreement with the earlier work of Lester and 
Crane (1959} who showed that when E. coli B4 was grown 
aerobically, ubiquinone and roenaquinone were present, but 
when grown anaerobically, only menaquinone was present. 
Bishop and King (1962J demonstrated that when cells 
of E. coli were meahanically broken, cell residues were 
obtained which possessed both ubiquinone and menaquinone, 
whereas Kashket and Brodie (1963a,b~) were able to separate 
ubiquinone and menaquinone by fractionating the cell-free 
preparation of E.coli. The 'heavy' fraction contained 
ubiquinone and most of the succinoxidase activity while 
the 'lighter ' fraction contained both ubiquinone anq mena-
quinone in the ratio of 10:1, This light fraction was found 
to oxidise NAD-linked substrates with coupled phosphorylation. 
Kashket ahd Brodie (1963b) therefore proposed that in E.coli 
ubiquinone was linked with succinoxidase activity while 
menaquinone was linked with NADH-cytochrame b reduotase. 
More recently in experiments to determine the funct ion 
of ubiquinone in E. coli, Cox et al. (1970) have reported 
that ubiquinone-deficient strains when grown under aerobic 
conditions have gre~tly impaired NADH and lactate oxidase 
activities. These activities were restored by ' the addition 
of ubiqu~none (Q-1}. On comparison of the percentage 
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reduction of f lavin, cytochrome .b, and cyt,ochrome a 2 in the 
aerobic steady state in membranes from normal and ubiquinone-
deficient strains, and the effect of respiratory inhibitors 
on these percentages, uniquinone was shown to fu·nction at 
more than one site in t~e electron~transport chain. A 
I 
scheme was t4erefore proposed in .which ubisemiq~inone, com-
plexed .to an electron carrier, functioned in at least two 
positions in the eleqtron-transport sequenc~ before and 
after cytochrome b1 • For efficient aerobic electron trans-
• .... . 
port, ubiquinone was required in considerable molar excess 
over other components of the electron transport system 
(Newton et al., 1972). A comparison of ~erobic steady 
states of cytochrome b1 in membranes from normal, partially 
', 
ubiquinone-defici·ent, and completely ubiquinone-deficient 
strains, indicated that the proposed sites of ubiquinone 
' 
function in the scheme mentioned previously (Cox et al., 
1970} are equally affected ny the partial depletion of the 
quinone (Newton et al., l972}. Further; these workers 
suggested that ubiquinone could be involved as a mobile 
substrate in additional step(s} between the electron trans-
. ' 
port chain and adenosine triphosphate formation. 
A mutant strain of' E. · cn•li deficient in menaquinone, 
or vitamin K2 has been isolated by Newton et al., (1971) . 
Under aerobic conditions this mutant strain grew at the 
same rate as a normal strain. However, under anaerobic 
conditions, the menaquinone-deficient mutant grew slowly 
on glucose. Another mutant, deficient in both menaquinone 
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and ubiquinone, did not grow at all under the same conditions. 
It was shown by these workers that menaquinone was not 
involved in the aerobic metabolism of E.coli but was 
required for the anaerobic metabolism of reactions involved 
in pyrimidine bio~ynthesis, namely the oxidation of dihydro-
orotate to orotate with fumarate as hydrogen acceptor. 
SECTION 2.1 GENETIC AND BIOCHEMICAL CHARACTERISATION 
OF A MUTANT WHICH LACKS THE ABILITY TO 
FORM 4-HYDROXYBENZOATE. 
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INTRODUCTION. 
In E. coli K-12, the first specific precursor in the 
biosynthesis of ubiquinone is 4-hydroxybenzoate and the 
formation of this compound from chorismate was initially 
shown by Gibson and Gibson (1962) using crude cell-free 
extracts of~- aerogenes 62-1. It was also demonstrated 
that 4-hydroxybenzoate could be formed chemd.cally from 
chorismate (Gibson and Gibson 1962; Gibson 1964). Although 
the enzymic formation of 4-hydroxyb,enzoate appeared to be 
stimulated by NAD, the enzyme(s) concerned in the reaction 
had not been studied in any detail (Gibson and Gibson, 
1964). The NAD stimulation has since been found to be - due 
to the formation of 2,3-dihydroxybenzoate, which also arises 
from chorismate and has an absorption maximum at 252 nm, in 
the same region as 4-hydroxybenzoate (Young et al. 1967~). 
A mutant strain of E. coli K-12 which is unable to carry 
- . 
out the first specific reaction of ubiquinone biosynthesis 
had been isolated by G.B. Cox and this section describes 
the genetic and biochemical characterization of this mutant 
strain. The original mutation was transferred into a ne J 
strain (AN244) which was used to characterize this mutation. 
In order to determine a ubiquinone-deficient strain, the 
lack of ability to grow on succinate as sole carbon source 
(and therefore to be a ubiquinone-deficient mutant), 
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depends on the rationale that follows. Since ubiquinone is 
implicated in membrane-bound electron transport processes 
(Crane et al. 1957), a mutant which lacks ubiquinone would 
not b e able to grow on a particular carbon source if an 
essential step in its metabolism involves electron trans-
port. Therefore ubiquinone-deficient strains might be 
found among mutants unable to grow on succinate, malate or 
lac tate as sole carbon source (Cox, Gibson and Pittard, 1968). 
A mutant strain which lacks the ability to form 4-hydroxy-
benzoate would also be expected not to accumulate any of the 
known precursors of ubiquinone and not form ubiquinone unless 
supplied with 4-hydroxybenzoate. 
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MATERIALS AND METHODS. 
Chemicals. 
All chemicals used were obtained commercially and were 
of analytical grade, with the exception of chorismic acid 
which was prepared by the method of Gibson (1968). 
Bacterial Strains. 
A list of bacterial strains used in this section is 
shown in Table I. All the strains used were derived from 
E. coli K-12. Cultures were maintained on nutrient agar 
and sub-cultured monthly. 
Media. 
The minimal medium used was that described by Monad, 
Cohen-Bazire and Cohn (1951), and described as medium 56. 
Medium 56. K2~PO 4 265g 
NaH2Po 4 . 2H2o 153g 
Mgso 4 . 7H 2o Sg 
(NH4 ) so 4 50g 2 
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TABLE I. STRAINS OF E.COLI USED. 
Strain 
AN58 
AN244 
AN245 
AN246 
AN247 
Relevant Genetic 
. a Loci-
proA2, pheAl, tyrA4, 
tryp-401, argE3. 
ubiC401 
proA2, argE3, 
pheAl, tyrA4. 
proA2, pheAl, 
tyrA4, metA 
proA2, pheAl 
tyrA4, ubiC401. 
-
Other Information 
Derived from AB259 after 
treatment with N-methyl-N'-
nitrosoguanidine and subse-
quent ·recombination. (See text.) 
Derived from AN58 by trans-
duction (Huang and Gibson, 
1970). 
Derived from AN245 by trans-
duction using PiKc grown on 
arg+ derivative of PA505MPE11 
(Schwartz, ,19,6 6) . 
Derived from AN246 by trans -
duction with PlKc grown on 
AN244. 
PA505MPE11 metA, argH Schwartz (1966). 
AT2246 
AB2830 
AB3311 
AN67 
leu-13, thr-13 
aroC 
metB 
proA2, pheAl, 
tyrA4, tryp401, 
men 
-
Hfr PIO (Schwartz, 1966). 
Pittard and Wallace (1966). 
Hfr Reeves 
Derived from AN58 by tra ns-
duction. 
a The genetic nomenclature is that used by Taylor 
(1970), except for ubiC which is described in 
this thesis and men- which describes a gene con-
cerned with menaquTnone biosynthesis. 
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TABLE II. CONCENTRATION OF GROWTH FACTORS IN DEFINED MEDIA. 
SUPPLEMENTS FINAL CONCENTRATION 
L-arginine 0.8 rnM 
L-phenylalanine 0.2 rnM 
L-tyrosine 0.1 mM 
L-tryptophan 0.1 rnM 
L-methionine 0.2 mM 
L-proline 1 rnM 
2,3-dihydroxybenzoate 10 µM 
4-hydroxybenzoate 10 µM 
Thiamine 0.02 µ rs'l 
Succinate 20 rnM 
* Glucose 30 mM 
* In anaerobic experiments glucose was used at 
a concentration of 30 mM, but in other exper-
iments glucose was used in excess of 30 mM. 
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The salts were dissolved and made up to a volume of 5 1 
with distilled water. Chloroform (5 ml) was added to 
prevent bacterial growth in the stored medium. This solution 
was diluted 1:5 before use. Calcium and iron were added to 
the medium (1 ml/1) from · stock solutions (1% Ca(NO 3 ) , 2 
0.05% F~so 4 .7~2o). Half-strength medium is referred to as 
56 and is medium 56 diluted 1:2 by vol . . Sterile solutions 
2 
of supplements were added to th~ medi·a as required in the 
concentrations shown in Table II. The nutrient broth used 
for genetic experiments was that described by Luria and 
Burrous (1957) and consisted of the following:-
Difeo Bacto Tryptone 10g 
Difeo Yeast Extract 5g 
NaCl 10g 
Distilled water lt 
The pH was · adjusted to 7.5 with NaOH. g broth was nutrient 
broth supplemented with 2.5 x l0- 3M cac1 2 . Solid medium 
was obtained by adding 2% (w/v) agar, in the case of minimal 
medium, and 1% (w/v) agar, in the case of nutrient medium. 
Tests for Growth Response to 4-Hydroxyben~oate. 
Growth responses of the various bacterial strains to 
4-hydroxybenzoate were difficult to detect on a solid medium 
since low concentrations of 4-hydroxybenzoate are often found 
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as a contaminant in media. To prevent the formation o 
4-hydroxybenzoate during the preparation of media, solutions 
of tyrosine were s eri ized by filtration e Alternativ ly, 
4-aminobenzoate at a final concentration of S0µM was added 
to the medium containing succinate as carbon source. Davis 
(1951) observed that concentrations of 4-aminobenzoate of 
the order of SmM inhibited the growth of E. coli strains 
and that th·s inhibition f growth could be reversed by the 
addition of 4-hydro_'ybenzoate at a concent ation of SOµM. 
The growth of the wild type strain was not visibly affecLed 
at the concentration of 4-aminobenzoate used. Growth 
esponses of the multiple aromatic auxo roph AB2830 and the 
ubiC strain ~..N247 to varying concentrations o 4-hydroxy-
benzoate, were carried out in a liquid medium supplemented 
with the required g owth factors and succinate (20mM) as 
carbon source. The inoculum for the T-tubes was obtained by 
incubating the cells from a nutrient aga 0 slope at 37 C ror 
24 h in nutrient broth. These cells were concentrated by 
centrifuga ion and made up to 1 ml with minimal medium. 
T-tubes c ntaining 10 m of the liquid medium and supplements 
were ino lated with 0.1 ml of the concentrated suspe sion 
to give an initial popu ation of 10 6 cells. The T~tube 
0 
were then shaken for 20 hat 37 c and growth was measured 
using a Spekker o orimeter with a neutral density fiiter. 
28. 
Genetic Techniques. 
(a) Isolation of a streptomycin-resistant mutant. 
The cells from a nutrient agar slope of strain AN244 
were incubated overnight at 37°c in nutrient broth. A 
spontaneous streptomycin-resistant mutant of A.N244 was 
isolated after spreading 0.1 ml of this culture onto 
nutrient agar plates containing 0.2 mg/ml of streptomycin 
sulphate and incubating overnight at 37°c. 
(b) Soft agar overlay technique. 
An aliquot of a sample (0.1 ml) was pipetted into a 
tube containing 3 ml of molten agar (1% w/v agar in medium 
0 
56) which had been stored at 45-50 c before use. The total 
2 
contents of the tube were poured onto an agar plate, and 
then spread evenly. 
(c) Conjugation technique. 
The technique used for conjugation experiments was that 
described by Taylor and Thoman (1964). Experiments between 
Hfr male strains and F strains were designed to map new 
mutations i.e. to determine the approximate position of the 
genetic loci of a mutation in relation to other known markers. 
This was achieved by selecting recombinants on appropriate 
media. Male and female cells were grown in Luria broth to 
logarithmic phase (~10 8 cells/ml). The male culture (1ml) 
was mixed gently with the female culture (9ml) for 5 min. 
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The time of entry of chromosomal markers was determined by 
sampling an aliquot (1ml) of the mixture at regular inter-
vals, agitating on a Vortex mixer to separate the mating 
pairs, and selecting for recombinants using the soft agar 
overlay technique. Growth of parental cells was inhibited 
by the use of an appropriate defined medium or by the action 
of an antibiotic. 
(d) - Preparation of phage lysates. 
Bacteria on which the generalized transducing bacterio-
phage PlKc was to be prepared, were grown in g broth to a 
cell density of about 10 9 cells/ml. The qulture (1.5ml) was 
mixed with a phage Pl lysate (0.5ml - 10 9 p.f.u./ml) and 
aliquots (0.1ml) were overlaid onto B plates using the soft 
agar overlay technique. After incubation ·at 37°c for 8 h, 
B broth (2 ml) was added to each plate. Following a further 
incubation for approximately 16 h, the soft agar was removed 
from the plate, macerated to pulp, and then centrifuged to 
remove cell debris and agar before being filtered through a 
Millipore membrane filter. Preparations were stored at 4°c 
sterile, screw-cap Pyrex test tubes. The number of plaque 
forming units/ml of undiluted phage preparation was approx-
. . 10 6 1 9 imation to O . 
(e) Transduction technique. 
Transduction experLments u ing the generalized trans-
ducing bacteriophage PlKc were performed according to the 
method of Pittard 1965)~ Bacteria to be transduced were 
grown overnighting broth (10 ml), centriluged and resus-
pended in g broth (1 ml). An aliquot of the cell suspension 
9 (~lo cells) was mixed w ' th appropriate volume of phage 
lysate, using an approximate phage to cell ratio of 1:1 in 
a total volume of 5 ml. After incubation at 37°c for 20 min, 
the cells were centrifuged and resuspended in minimal medium 
(1 ml). Diluted and undiluted aliquots were spread on plates 
of the appropriate selection media. Plates were incubated 
0 
at 37 C for 2 days before examining the colonies of trans-
ductants that appeared. 
Preparation of Cell-Free Extracts . 
• 
Cultures were grown in minimal media supplemented, as 
required, with the growth factors, as in Table I. Cells 
were harvested in early stationary phase of growth and were 
washed with cold 0.9% NaCl. Each gram of eels (wet weight) 
was suspended in 3 ml cold 0.05M Tris-Hcl buffer (pH 8.0) 
containing 10- 3M EDTA, and smashed in a French Press at 
20,000 psi. The cell extracts were then centrifuged at 
25,000 x g for 20 min at 4°c and the supernatants were used 
as the cell-free extracts. 
31. 
Assay for 4-Hydroxybenzoate. 
Chorismate lyase activity in strains AN246 and AN247 
was determined using 0.5ml of cell-free extract (about 
15 mg of protein) in a reaction mixture containing 2 µmoles 
of chorismate, 50 µmoles of L-tryptophan, 50 µmoles of 
Tris-HCl buffer (pH 8.0), and 1 µmole of EDTN in a final 
volume of 1 ml. L-tryptophan was added to repress anthran-
ilate synthetase activity (Edwards et al., 1964) as this 
enzymic activity was normal in strains AN246 and AN247. 
Hence chorismate could be lost to this pathway. The 
reaction mixture and appropriate blank were incubated at 
0 37 C for specific time intervals up to 3 h. The pH was 
lowered to 4.0 by the addition of 0.5 ml of 0.2M sodium 
acetate buffer (pH 4.0) and samples were refrigerated 
until required for extraction (pH 4.0 was chosen since 
little or no chorismate was extracted at this pH). Samples 
were extracted with 5 ml diethylether. The ether was dried 
over anhydrous sodium sulphate and the spectra were measured 
f om 230 nm to 360 nm with a Model 15 Cary Spectrophoto-
meter. 4-Hydroxybenzoate in ether has an absorption max-
imum at 252 nm ( E = 16,400). The spectra were always 
examined in detail, for in some experiments small amounts 
of 2,3- dihydroxybenzoate were formed. This compound also 
has a peak of absorpt i on in the 250 nm region (s = 7,200 
at 252 nm). However, the formation of 2, 3- dihydroxy-
benzoate i n the reaction mixture could readily be observed 
32. 
by the presence of a second peak of absorption at 320 nm 
(s - 3,340). An appropriate correction was therefore made 
when necessary. 
Determination of Ubiquinone. 
For the estimation of ubiquinone content in cells, 
approximately 3 to 5 g cells (wet weight) were continuously 
extracted in a Soxhlet thimble with 100 ml acetone for 2 h. 
The acetone was removed by evaporat~on and the residue was 
then extracted with 50 ml of light petroleum ether 
0 0 (b.p. 40 - 60 C). This extract was transferred to another 
container, evaporated to a small volume (1-2 ml) and then 
chromatographed on thick layer silica gel plates in a 
mixture of light petroleum ether (b.p. 40° - 60°c) -
chloroform (3:7 by vol.) as described by Cox et al. (1968). 
The yellow bands of ubiquinone were removed from the plates, 
eluted from the silica gel with ether and the ultraviolet 
spectra recorded using a Model 15 Cary spectrophotometer. 
Th~ concentration of ubiquinone was calculated using a 
molar extinction coefficient of 14,956 (272 nm) 5 
Test for the Presence of 4-Hydroxybenzoate in Culture 
Supernatants. 
Cultures of the various strains were grown in 1 1 
batches of a glucose mineral salts medium supplemented with 
33. 
the various g r owth f ac t o r s as r equired - see Table I. 
9 Cultures were grown to a cell dens i t y o f about 10 cells/ml 
as deter mined by measur ing t he tur b i d ity in a Klett-Summer-
son colorimeter. The cells we r e r emoved by centrifugation 
at 17,500 x g f or 15 min. The supernatants (100ml) were 
acidified to pH 4.0 with dilute hydroc h l o ric acid befor e 
extracting with 3 v o l . ether. The ether e xtract was then 
extracted with O.lM NaOH and the aqueous layer was then 
acidified and re-extracted with ether. The final ether 
extract was dried over anhydrous sodium sul phate b e for e 
e v aporating to a small volume and app l y i ng to thin layer 
plates of silica gel. The plates were dev e l oped in 
chloroform-methanol-acetic acid (60:40:0.5 by vol.). 
Protein Determination. 
Protein was estimated using the Falin reagent a s 
described by Lowry et al. (1951) , and bovine serurn albumin 
(Pentex) as a standard. 
34. 
RESULTS. 
Isolation of a Strain Carrying a Mutation Affecting 
4-Hydroxyb~nzoate Synthesis. 
During a search for strains of E. coli unable to form 
ubiquinone (Cox, Gibson, Pittard, 1968}, a new strain was 
isolated. It would not grow with DL-lactate as sole source 
of carbon, but would grow on glucose (G.B.Cox, personal 
communication). This strain could not form ~biquinone when 
grown on a glucose medium, but would do so if 4-hydroxy-
benzoate, was included in the medium. The conclusion drawn 
was that the reaction affected in ubiquinone biosynthesis 
was the conversion of chorisimate to 4-hydroxybenzoate and 
the gene concerned was designated ubiC. However, the 
ubiC strain did not grow when the medium contained 
4-hydroxybenzoate and either lactate or succinate. The 
possibility that there were other mutations affecting 
ubiquinone biosynthesis had therefore to be considered. 
Assuming there were two mutations, an interrupted mating 
experiment with the ubi mutant strain (female) and a wild 
type Hfr was carried out in order to separate the two 
mutations. Recombinants were selected on the basis of 
their ability to grow on a succinate medium containing 
35 .. 
4-hydroxybenzoate. One of these .recombinants was isolated 
(strain AN244 ) and the mutation causing the requirement for 
4-hydroxybenzoate was designated ubiC401 (G.B. Cox, personal 
communication) • 
Mapping of the ubiC Mutation. 
Interrupted mating experiments were carried out to 
locate the approximate position of the· ubiC mutation on the 
chromosome of E.coli. The results of experiments in which 
the female strain AN244 (ubiC-) was mated with the Hfr strain 
AB3311 are shown in Figure 2.1. Selection for ubiC+ recom-
binants was based on the ability of these recombinants to 
grow on succinate as sole carbon source . The ubiC+ allele 
is transferred approximately 17 min after pair formation 
indicating a location at about minute 80 depending on the 
lag period. As strain AB3311 transfers its chromosome from 
minute 74 with a clockwise order of gene transfer, the ubiC 
gene is transferred as an early marker. The Hf~ AT2246 has 
its origin of transfer near malB at minute 79 (Schwartz, 
1966), and transfers its chromosome in the opposite direction 
to AB3311. Therefore, the strain AT2246 was used in an 
interrupted mating experiment. This strain did not transfer 
the ubiC gene as an early marker, although normal numbers of 
arg+ recombinants were obtained in an interrupted mating 
experiment with the female strain JP58 (argE-, ilvC-), 
indicating that the ubiC gene was on the clockwise side of 
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malB. A cotransduction test was then carried out with 
strain AN246 (derived as shown in Table I) as recipient 
and strain AN244 (ubiC) as donor. On examinat i on of the 
metA+ transductants of strain AN246, 11% (9 out of 80 
colonies tested) were shown to be ubiC-also. The ubiC 
gene was therefore located near minute 79 (Figure 2.2) and 
one of the ubiC transductant strains (AN247) was retained 
for further characterization. 
Characterization of the ubiC Mutant. 
(a) Growth response to 4-hydroxybenzoate. 
Strain AN247 (ubiC-), gave a growth response to 4-hydroxy-
benzoate on succinate agar plates (Figure 2.3). The level of 
response in liquid medium was compared with that of an auxo-
trophic strain of E.coli (AB2830) unable to form choris-
mate. The ubiC strain responded to the same levels of 
4-hydroxybenzoate as did the multiple aromatic auxotroph 
(Figure 2.4), which is in contrast to some ubiA stra~ns 
which only respond to relatively high levels of 4-hydroxy-
benzoate (Cox et al., 1968). 
(b) Accumulation of 4-hydroxybenzoate. 
The presence of 4-hydroxybenzoate in the culture medium 
of ubiC mutants could not be detected, whereas in culture 
fluids of wild type strains, 4-hydroxybenzoate is always 
formed. An excess of 4-hydroxybenzoate is excreted into 
ilvC 
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the medium in the normal strain, AN246, whereas in the case 
of the two ubiC strains, AN244 and AN247, there is very 
little 4-hydroxybenzoate present (Figure 2.5). The small 
amount that is present could be due to the presence of 
4-hydroxybenzoate formed non-enzymically from chorismate 
during the growth of cultures, or from trace contamination 
of 4-hydroxybenzoate in the medium. 
(c) Ubiquinone levels. 
The ubiquinone level in the ubiC mutant AN247 is very 
low. Cells of this strain when grown in a glucose-mineral 
salts medium formed only 20 nmoles of ubiquinone per g wet 
weight of cells. This value is very close to the limit of 
detection of ubiquinone and is considered to be a trace amount 
only. Once again it is confirmed that strain AN247 (ubiC-) 
is unable to form ubiquinone. On growing cells of AN247 
in the same medium supplemented with 4-hydroxybenzoate 
(100 µM), the ubiquinone concentration increases to 150 
nmoles per g wet weight of cells, which is the normal level 
found in E.coli under the growth conditions used. 
(d) Chorismate lyase activity. 
Tests for chorismate lyase in the ubiC transductant 
strain AN247 and the parent strain AN246 were carried out 
and the results are shown in Figure 2.6. In order to 
detect enzymic activities which convert chorismate along 
the minor pathways of aromatic metabolism, strains with 
FIGURE 2. 5 
AN246 
~---~ .. -~ 
···•--' 
-
AN244 
A 
B 
C 
AN247 
Chromatography of culture fluids of the 
normal strain of E. coli, AN246, and the 
two ubiC mutants, AN244 and AN247, to 
show the accumulation of 4-hydroxybenzoate. 
4-Hydroxybenzoate is detected by spraying 
with p-nitraniline. The compounds are : 
A. unidentified; B. 4-hydroxybenzoate 
(colour - red-brown); c. 2,3 dihydroxy-
benzoate (colour - purple). 
-Cl') 
~ 125 0 
E 
C 
-
fa 100 
~ 
~ 
0 
u_ 75 
LU 
t--
4: 
0 50 
N 
z 
LU 
c!l 
~ 25 
0 
~ 
0 
>- 0 ..............•..............•..............•.......................•......................• 
I 
I 
~ 0 
FIGURE 2. 6 
0.5 1.0 1.5 2.0 2.5 
TIME(h) 
The formation of 4-hydroxybenzoate from 
chorismate by cell-free extracts of 
strain AN246 (wild type) •--• 
and strain AN247 (ubiC-) •-- --• 
Conditions are those describeo in 
MATERIALS Ail\JD METHODS. 
3.0 
38. 
metabolic blocks preventing the metabolism of chorismate 
along the major pathways must be used. Examples of the 
minor pathways are the conversion of chorismate to 4-amino-
benzoate (Huang and Gibson, 1970) as well as the present 
case, the conversion of chorismate to 4-hydroxybenzoate. 
Hence, in both the parent strain (AN246) and the trans-
ductant strain (AN247), chorismate mutase-prephenate 
dehydratase and chorismate mutase-prephenate dehydrogenase 
activities are absent. L-tryptophan was included in the 
reaction mixture to inhibit anthranilate synthetase activity. 
Strain AN247 (ubiC-) showed no chorismate lyase activity 
while the ubiC+ strain, AN246, formed 4~hydroxybenzoate 
from chorismate. 4-Hydroxybenzoate was identified and con-
firmed by its fluorescence characteristics (activation, 
300 nm, emission 346 nm; uncorrected), by chromatography on 
silica gel and by the red-brown colour that is obtained 
when it is sprayed with the E-nitraniline reagent. (Smith, 
1960). 
39. 
DISCUSSION. 
The ubiC gene was shown by interrupted mating exper-
iments with the Hfr AB3311 and more accurately with trans-
duction experiments, to be located at about minute 79 on 
the E. coli chromosome. The fact that the ubiC gene is not 
transferred as an early marker by strain AT2246 also supports 
this location on the chromosome. This is in the s_ame region 
as the ubiA gene which codes for the enzyme catalysing the 
second specific reaction in ubiquinone biosynthesis, namely 
4-hydroxybenzoate octaprenyltransferase (Young et al., 1972). 
The locations on the E, coli chromosome of seven genes con-
cerned with ubiquinone biosynthesis have now been determined, 
and these are shown in Figure 2.7 (Cox, Gibson and Pittard, 
1968; Cox et al., 1969; Young et al., 1971; Stroobant et al., 
1972; Young et al., 1972;). While the ubiF, ubiG and ub iH 
genes are well scattered around the chromosome, there are 
two clusters of closely linked genes, namely the ubiB, ubiD, 
and ubiE genes and the ubiA and ubiC genes. The significance, 
if any, of the clustering has yet to be determined but it 
may be noted that both the ubiC and ubiA genes code for 
consecutive reactions, but this does not appear to apply 
to the other cluster of genes. 
PIGllR.E 2 . 7 
0, 
190 
ubiG 
~enetic mao of the E. coli chromosome 
showinq the positions of the ubi oenes. 
The scale on the genetic map is in 
minutes an~ is based on the map of the 
E. coli chromoso~e given bv Taylor (1970). 
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The observations presented here indicate that a 
mutation in a gene designated ubiC, results in the loss 
of the ability to carry out the conversion of chorismate 
to 4-hydroxybenzoate. This conclusion is based on enzymic 
studies and on the requirement of 4-hydroxybenzoate for 
ubiquinone formation. Although a small amount of ubi-
quinone is formed by the ubiC strain in the absence of 
added 4-hydroxybenzoate, this could be due to traces of 
4-hydroxybenzoate formed from the non-enzymic break-down 
of chorismate, or formed from tyrosine during the growth 
of cultures. 
-SECTION 2.2 REGULATION OF CHORISMA.TE LYASE. 
J 
41. 
INTRODU&rION. 
Few studies have been carried out on the regulation 
of the ubiquinone pathway. In this section mutant strains 
of E.coli have been studied with respect to the regulation 
of ubiquinone biosynthesis in whole cells. These studies 
have been limited to a consideration of effects of oxygen-
ation on ubiquinone formation. 
The mutant strains of E. coli used were of two types. 
Strain AN58 is a triple mutant (as described in Table I 
Section 2.1) and was used as the wild type strain. Strain 
AN67 is a triple mutant which lacks the ability to form 
menaquinone. Since ubiquinone and menaquinone are struct-
urally related and are both derived from the branch-point 
compound, it was of interest to investigate the effects of 
the presence and absence of these compounds on chorismate 
lyase activity. This was done by growing cells under 
different conditions of aeration, since ubiquinone and 
rnenaquinone are present in aerobically grown cells of 
E. coli while under anaerobic conditions ubiauinone is 
absent and the menaquinone levels are increased (Lester 
and Crane, 1959; Polglase et al., 1966; Newton et al., 1971). 
42 . 
The effect of the level of 2-octaprenylphenol on 
chorismate lyase levels was also investigated. 
2-0ctaprenylphenol is only found in anaerobically g r own 
cells of E. coli. By observing the 2-octaprenylphenol 
levels in normal and menaquinone-deficient strains when 
the cells were grown under anaerobic conditions 3 the 
comparison could easily be made. 
By estimating the levels of a biosynthetic inter-
mediate _in the ubiquinone pathway and comparing it with 
the level of chorisroate lyase present at the same stage 
of growth, the compound· governing the regutation of this 
enzyme may be determined. 
43. 
MATERIALS AND METHODS. 
Chemicals. 
All chemicals were obtained commercially and were of 
analytical grade with the exception of chorismic acid 
which was prepared by the method of Gibson (1968). 
Bacterial Strains. 
Strain AN58 and Strain AN67 (men) were used and are 
listed with their relevant genetic loci and other inform-
ation in Table I, Section 2.1. 
Media. 
The minimal medium used was that described by Monod, 
Cohen-Bazire and Cohn (1951). Sterile solutions of the 
supplements were added to this medium as required in the 
concentrations shown in Table II, Section 2.1. Where 
cells were grown under anaerobic conditions, the medium for 
the inoculum consisted of Difeo Casamino acids dissolved in 
1 t of distilled water to give a final concentration of 
0.6% in 40 i . Glucose was used as sole carbon source in 
all experiments. 
44. 
Growth of Cells. 
Cells were grown at 37°c in a New Brunswick Fermacell 
Fermenter. Under aerobic conditions, the rate of aeration 
was 2 cu. ft. per min and the speed of agitation was 300 
revolutions per min. Under anaerobic conditions the 
Fermacell was supplied with nitrogen and carbon dioxide 
and pH control was used. Oxygen free nitrogen was obtained 
by passing the nitrogen gas through a furnace of activated 
cupric oxide pellets at 140°c. The inoculum for aerobic 
growth consisted of cells washed with distilled water 
from ten nutrient agar slopes which had been incubated 
0 
overnight at 37 C. The inoculum for anaerobic growth con-
sisted of cells washed from twenty nutrient agar slopes 
with the Ca~amino acid solution. The Casamino acid 
solution together with the cell suspension was poured 
into screw cap bottles which were then placed in anaerobic 
culture jars containing a 'cold' catalyst. The jars were 
partially evacuated, filled with hydrogen and incubated 
0 for approximately 30 hat 37 C. Cells were grown in minimal 
medium with supplements added as required, and glucose was 
the sole carbon source. Cells were harvested at early log 
phase, mid-log phase, stationary phase, and late stationary 
phase of growth. The growth curves for each organism were 
followed in order to determine the time of harvesting. 
Cells were harvested, centrifuged at 17,500 x g for 10 min 
and stored at -20°c until required for analysis. 
45. 
Preparation of Cell-Free Extracts. 
Cells were resuspended in 3 vol. of cold O~lM Tris-
HCl buffer (pH 8.0} containing 10-3 M EDTA, and smashed 
in a French Press at 20,000 psi. Cell debris was removed 
by centrifugation at 25,000 x g for 30 min giving the 
cell-free extract. 
Assay TeGhniques. 
(a) Determination of ubiquinone, menaquinone and 
2-octaprenylphenol. 
The method of estimating the concentrations of ubi-
quinone, menaquinone and 2-octaprenylphenol was the same 
as that used for the estimation of ubiquinone content in 
Section 2.1. Menaquinone and 2-octaprenylphenol were 
isolated from the same plates as ubiquinone. The yellow 
bands of ubiquinone and menaquinone were each eluted into 
diethyl ether. The position of 2-octaprenylphenol was 
detected by spraying a small section of the plate with the 
E-nitraniline spray (Cox et al., 1969), giving a dark red 
band running above ubiquinone. This area of the plate was 
then extracted into diethyl ether. The ubiquinone, mena-
quinone and 2-octaprenylphenol concentrations were determ-
ined from their ultraviolet spectra in ether recorded on a 
Model 15 Cary Spectr ophotometer. A molar extinction value 
46. 
of 19, 89 at 248 run, was used for menaquinone, while a 
molar extinction of 2,000 at 274 nm was used for 2-octa-
prenylphenol . 
(b) Me surement of oxygen uptake. 
Oxygen uptake by cell-free extracts was measured as 
described by Cox et al. (1970). A Titron oxygen electrode 
(Titron Instruments, Melbourne, Victoria) modified as 
described by Snoswell (1966) was used. The reaction 
mixture in a final volume of 2.5 ml contained 15 mM sodium-
potassium phosphate buffer (pH 7.4), 1.9mM Mgcl 2 , 100 µl 
cell-free extract (3-5 mg protein) and 3 µ moles NADH. 
(c) Estimation of chorismate lyase activity. 
Chorismate lyase activity was determined in the same 
manner as described in Section 2.1., namely by estimating 
the amount of 4-hydroxybenzoate formed from cell-free 
extracts on a Model 15 Cary Spectrophotometer. 
(d) Protein Determination. 
Protein was determined in cell-free extracts using 
the Folin reagent as described by Lowry et al. (1951). 
47. 
RESOLT .. 
Growth Curves and Growth Yields for the Wild-ty'.Q_e Strain 
and the Menaquinone-Deficient Strain. 
When comparing the aerobic growth curves for the 
normal strain AN58 and the menaquinone-deficient strain 
AN67, growing on a medium with glucose as sole source 
of carbon, there was lit~le difference in the two curves. 
The mean generdtion time for both strains was 1 hand the 
growth yields were comparable (Figures 2,8 and 2.9). 
However, when both strains were grown under anaerobic 
conditions, there was a marked difference in both the 
growth curves and growth yields (Figures 2.10 and 2.11). 
A linear curve was obtained for strain AN67 (men-) 
indicating a possible .requiLement for growth. Also the 
mean generation time for strain AN67 (men-) was 3 h whereas 
for strain AN58 (wild type) it was 1 h. Slightly lower 
yields were obtained for the normal strain when grown 
under anaerobic ~onditions . However the yield of the 
menaquinone-deficient stLain dropped to one third under 
these same conditions. This made the comparison of the 
two strains under anaerobic conditions more difficult. 
To estimate the quinone content and chorismate lyase 
activity, five or six samples were usually taken during 
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FIGURE 2.10 Effect of the levels of menaquinone and 
2-octaprenylphenol on the level of chorismate 
lyase in strain AN58 under anaerobic conditions. 
No ubiquinone could be detected under these 
conditions. The time was measured starting at 
inoculation. 
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FIGURE 2 .11 Gro,_,..,th curve for strain AN67 (men ) 
grown under anaerobic conditions. 
48. 
the growth of the normal strctin. However, it was only 
possible to take two samples with the menaquinone-deficient 
strain due to the low growth yield. 
NADH Oxidase Activities. 
The NADH oxidase activities in cell-free extracts 
from cells that were grown anaerobically were determined 
for strain AN58 (wild type) and strain AN67 (men-). The 
NADH oxidase level in the two strains was compared 
(Table III) and it was found that the NADH oxidase 
activity for both the menaquinone-deficient strain and the 
normal strain were the same i.e. 90 ng-atoms o2 per min 
per mg protein. This indicated that the cells had been 
grown under completely anaerobic conditions since aerobic 
levels for a normal strain are 780 ng~atoms o2 _per min 
per mg protein and for a menaquinone-deficient strain 
are 860 ng-atoms o2 per min per mg protein (Newton et al. 
1971). 
Effect of Ubiquinone on Chorismate Lyase Activi~y under 
Aerobic Conditions. 
The concentration of ubiquinone was estimated together 
with chorismate lyase activity in both strains at various 
stages during the growth cycle. Under aerobic conditions, 
49. 
TABLE III. NADH Oxidase Activities in Cell~ree Extracts 
Klett 
Units 
182 
275 
278 
282 
288 
of Two Strains AN58 andAN67 Under Anaerobic 
Conditions. 
o2 uptake for Strain AN58 (wild type} 
(ng-atoms per min Klett 
per mg protein) Units 
87 70 
62 120 
46 
33 
35 
o2 uptake for Strain AN67 (men-) (ng-
atoms per min per mg 
protein) 
100 
94 
Rates of oxygen uptake were measured with an oxygen 
electrode as described in Materials and Methods (this 
section). The endogenous oxygen uptake (about 10 ng-atoms 
of o2 per min per 100 µl) has been subtracted. 
so. 
strain AN58 (wild type) showed a maximum concentration of 
ubiquinone with a corresponding minimum concentration of 
chorismate lyase activity; the amount of 4-hydroxybenzoate 
formed is an indication of the level of chorismate lyase 
activity present in the cell at any particular stage of 
growth (Figure 2,8). Strain AN67 (men-), the quinone 
deficient strain, showed a pattern quite the reverse under 
aerobic conditions (Figure 2,9). Both the concentration 
of ubiquinone and the level of chorismate lyase activity 
were at a minimum during stationary phase of growth. If 
the ratio of 4-hydroxybenzoate concentration to ubiquin-
one concentration for strain AN58 (wild type) and strain 
AN67 (men-) is calculated (Table IV), then for a given 
concentration of ubiquinone, the level of chorismate lyase 
activity decreases in the early stages of growth and then 
rises again toward the end of the growth cycle. 
Effect of Ubiquinone and 2-Octaprenylphe~ok ~ Chori smate 
Lyase Activity under Anaerobic Conditions. 
The most notable effect of ubiquinone on growth i s 
observed under anaerobic conditions., When strain AN58 
(wild type) is grown under anaerobic conditions, the level 
of chorismate lyase activity rises to a maximum at early 
stationary phase or growth and then decreases markedly 
in late stationary phase of growth (Figure 2.10). This 
i$ the opposite effect to strain AN58 (wild type) when 
TABLE IV. 
Klett 
Units 
175 
353 
375 
380 
51. 
Ratio of 4-Hydroxybenzoate Concentration 
C 
to Ubiquinone Concentration. 
Strain AN58 (wild 
type) Aerobically 
grown. 
1.632 
0.837 
0.612 
1.08 
Klett 
Units 
45 
200 
310 
340 
350 
355 
Strain AN67 (men-) 
Aerobically 
grown. 
1.90 
0.55 
0.43 
0.44 
0.62 
0.835 
52. 
grown under a erobic conditions (Figure 2.8). The absenc e 
of ubiquinone is no t ed under anaerobic conditions, whereas 
the concentration of menaquinone is relatively constant 
under the s e same growth conditions. However, the level 
of 2-octapre nylphenol fo r strain AN58 (wild type ) rises 
t o a max imum at a later stage in the growth cycle (late 
stationary phase ) compared to the level of chorismate 
lyase activ i t y (Figure 2.10) . When the ratio of 4-hydroxy 
-benzoat e t o 2-octaprenylphenol concentration is calcu-
lated, a shar p decrease is observed in the level of 
chorismate lyase a ctivity and this is followed by a 
constant leve l of activity (Table V). 
When the cells of the strain AN67 (men-) are grown 
under anaerobic conditions, ubiquinone is not usually 
found. If ubiquinone is present, the level is below t he 
accuracy o f detection. Although the results for strain 
AN67 (men- ) are too few to make a definite statement about 
any trend , they are nevertheless not unlike the results 
obtained f o r strain AN58 (wild type) grown under anaerobic 
condit i ons. The levels of 4-hydroxybenzoate and 2-octa-
prenylphe nol in strain AN67 (men-) at the same g r owth 
stage a r e comparable with the levels found in AN5 8 (wild 
type) g rown under anaerobic condi tions (Table VI ). 
TABLE V. 
Klett 
Units 
182 
275 
278 
282 
288 
53. 
Ratio of 4-Hydroxybenzoate Concentration 
to Ubiquinone Concentration. 
Strain AN58 (wild Klett 
type) Anaerobically Units 
grown. 
7.7 70 
6.0 120 
2.9 
2 . 0 
2.0 
Strain AN67 (Men-) 
Anaerobically 
gro~....m .. 
" 
6.9 
6.4 
TABLE VI. 
54. 
Strain AN67 (men-·) Grown Under Anaer~ic 
Conditions. 
Klett Units 4-Hydroxybenzoate 
concentration 
(nmoles/30 mg protein) 
2-Octaprenylphenol 
concentration 
(nmoles/g cells) 
70 249 36 
120 293 46 
55. 
DISCUSSTON. 
The results obtained from the regulation studies on 
whole cells in two strains of E. coli indicate that ubi-
quinone is not involved in the regulation or control of 
chorismate lyase activity. This study has been carried 
out with two strains, one of which is menaquinone 
~ 
deficient and one of which is normal. The effects observed 
on the level of chorismate lyase activity in both strains 
under both aerobic and anaerobic conditions indicate that 
ubiquinone does not regulate the conversion of chorismate 
to 4-hydroxybenzoate and that the level of chorismate 
lyase activity is independent of the ubiquinone concent-
ration at any given time (Figure 2.8, 2,9 and 2,10). 
The level of chorismate lyase activity in strain AN58 
(wild type) when grown under anaerobic conditions, initially 
rises then falls rapidly, and the increase in the 2-
octaprenylphenol concentration is coincident with this fall-
the peak of the 2-octaprenylphenol concentration is dis-
placed to the right which could be indicative of its 
synthesis at a later stage in the ubiquinone pathway 
(Figure 2.10). 
The rate of 4-hydroxybenzoate formation is steady until 
the enzymic reaction is regulated. Similarly the rate of 
2-octaprenylphenol formation remains steady and is governed 
56. 
by the supply of 4-hydroxybenzoate. Therefore, as the 
concentration of 2-octaprenylphenol builds up, there is 
a corresponding depletion in the concentration of 4-
hydroxybenzoate. If there is to be any regulation in the 
level of chorismate lyase activity, then a point would be 
reached where at a certain concentration of 2-octaprenyl-
phenol the first reaction in the ubiquinone pathway would 
be slowed down o a steady rate of production of 4-hydroxy-
benzoate i.e. the ratio of 4-hydroxybenzoate concentration 
to 2-octaprenylphenol concentration would stabilise at 
this stage. 
The ratio for strain AN58 (wild type) grown under 
anaerobic conditions (as seen in Table V) clearly takes 
this trend unlike the ratio of the concentration of 
4-hydroxybenzoate to ubiquinone concentration for the same 
strain under aerobic conditions. Therefore it may be con-
cluded that 2-octaprenylphenol or one of the preceding 
compounds regulates the level of chorismate lyase activity. 
A further point which suggests that 2-octaprenylphenol 
is regulating the level of chorismate lyase activity i s 
that under aerobic conditions, when 2-octaprenylphenol is 
absent, the level of chorismate lyase activity increases i n 
both strains (Figures 2.8 and 2.9) in stationary phase 
indicating that no regulation is taking place . Under 
anaerobic conditions when 2-octaprenylphenol is present, 
the level of chorismate lyase activity in strain AN58 
57. 
(wild type ) d rops markedly in the stationary phase of 
growth a nd does not rise again even in late stationary 
phase o f growth (Figure 2.10). 
SECTION 3.1 PURIFICATION OF CHORISMATE LYASE. 
58. 
INTRODUCTION. 
The only previous studies on chorismate lyase were 
made by Gibson and Gibson (1962, 1964) who were able to 
detect enzymic activity in crude cell-free extracts of 
A. aerogenes 62-1. These authors did not undertake any 
further investigations of the properties of the enzyme. 
It was therefore of interest to further characterize 
chorismate lyase, especially as nothing wa;s known about 
the properties of the enzymes responsible for the bio-
synthesis of ubiquinone. Efforts have been directed 
towards the development of a suitable procedure for the 
purification of the enzyme from extracts of a mutant 
strain of E.coli K-12 which had been blocked in the 
metabolic pathways that lead to tyrosine, phenylalanine, 
and tryptophan. Since the enzymic activity, as measured 
in crude extracts, was very low, the purification of the 
enzyme proved to be difficult. Nevertheless it was con-
sidered worthwhile devoting a great deal of time to t his 
project in order to gain for the first time information 
about an enzyme involved in the synthesis of a vitamin. 
In particular, it was of interest to determine if the low 
enzymic activity of crude extracts was due to the low 
concentration of the enzyme within the cell and/or to its 
low turnover number. 
59. 
MATERIALS AND METHODS. 
Chemicals. 
All chemicals used were obtained commercially and were 
of analytical grade. No further treatment was made to the 
chemicals unless stated otherwise. Chorismic acid was pre-
pared by the method of Gibson (1968). 
Microorganisms. 
The organism used as the source of chorismate lyase 
was E.coli AN58 (Section 2.1 - Table I) isolated by 
M. Huang. This organism is a suitable choice of bacterium 
as it is a strain carrying three mutations affecting the 
metabolism of chorismate towards the three major end-
products. 
Growth Conditions for Strain AN58. 
From the work carried out on the regulation of chor ismate 
lyase in whole cells (Section 2.2), it was established that 
the activity of the enzyme in this organism, reaches a maximum 
value in early stationary phase of growth. The cells from 
60. 
strain AN58 were therefore harvested at this point. The 
conditions for growing the cells and the preparation of 
cell-free extracts were the same as those described in 
Section 2.2. 
Storage of Cells. 
Cells were obtained in batches of 170 g from each run 
in the Fermacell fermenter (40 1). They were stored frozen 
0 
as a paste at -20 C. The activity of the enzyme remained 
stable for several months when stored in this manner. 
Determination of Chorismate Lyase Activity. 
The activity of the enzyme in various column fractions 
during the purification procedure was measured spectro-
photometrically by estimating the amount of 4-hydroxybenzo-
ate formed from chorismate after incubating the reaction 
mixture for 2 hat 37°c (Section 2.1). 
Units of Enzymic Activity. 
One unit of chorismate lyase activity is defined as 
that amount of enzyme which produces 1.0 nmole of product 
per min at 37°c. Specific activity is' defined as the 
number of units per min per mg of protein. 
61. 
Assais for Protein. 
Protein was determined in crude cell~free extracts as 
described by Lowry et al. (1951}, using bovine serum albumin 
as a standard, and in column fractions by measuring the 
absorption at 280 nm with a Gilford 240 spectrophotometer. 
Concentration of Protein. 
Protein solutions were concentrated by ultrafiltration 
using a Diaflo apparatus (Amicon Co.) in conjunction with 
a UM-2 membrane which has a molecular weight exclusion 
limit of 1,000. The pressure was maintained between 40 
and 60 lb/inch2 with nitrogen gas. 
Fractionation of Chorismate Lyase by High Speed 
Centrifugation. 
In order to determine whether the enzyme was present 
in the soluble part of the cell, or was attached to the 
membrane, high speed ultracentrifugation studies were 
carried out on crude cell-free extracts of strain AN58 as 
described by Jones and Redfearn (1966). The crude cell -
free extract was centrifuged at 35,000 x g for 30 min in a 
Beckman Model L ultracentrifuge to sediment the large 
particles. The turbid supernatant was further centrifuged 
62. 
at 105,000 x g for 90 min to yield the small particles. 
The remaining yellow supernatant is referred to as the 
high speed supernatant and is equivalent to the soluble 
fraction of the cell extract. The small and large particle 
fractions were each resuspended in 0.05 M Tris-HCl buffer 
(pH 8.0) containing 10-3 M EDTA, These fractions, as 
well as the final supernatant fraction, were assayed for 
enzymic activity. 
Treatment of Protein with Protamine SlifPf:ate. 
The amount of protamine sulphate required to completely 
precipitate the nucleic acid present in the crude extract 
was determined by titrating several aliquots of cell-free 
extract (5 ml) with increasing amounts of a 2% (w/v) pro-
tamine sulphate solution; the protamine sulphate was dis-
solved in 0.lM Tris~HCl buffer (pH 8.0) containing 10~3 
M EDTA. The precipitates which formed were removed by 
centrifugation and each supernatant was tested with a con-
centrated solution of ribosenucleic acid (10 mg/ml ) to 
detect excess protamine sulphate. The amount of protamine 
sulphate required for each preparation of cell-free extract 
was determined by such a titration. 
63. 
Fractionation of Protein Using Ammonium Sulphate. 
The weight of finally ground ammonium sulphate required 
to give the desired saturation was calculated using the 
equation of Kunitz (1952) viz1-
X 53.3 (S 2 
1 - 0.3s 2 
where X r epresents the number of g of solid ammonium sul-
phate to be added to 100 ml of solution of saturation s 1 
in order to change it to saturation s2 . 
64. 
RESULTS. 
Development of the Purification Prsced~e -
*' 
Preliminary Experiments~ 
Chorismate lyase was found to be a soluble enzyme as 
judged by the fact that all the enzymic activity was located 
in the high-speed supernatant fraction (Table I). Thus 
chorismate lyase differs from two other enzymes which are 
involved in the ubiquinone pathway and which have been 
shown by Young et al. (1972) to be membrane bound, 
(a) Protamine sulphate treatment. 
The treatment of the cell-free extract with 2% (w/v) 
protamine sulphate (Figure 3_1) indicates t h a t little 
activity is lost on the addition of increasing amounts of 
protamine sulphate. The amount of protamine sulphate 
required was determined for each batch of c el ls , since 
the protein content of the supernatant was var i able anc 
different batches of protamine sulphate also var ied 
slightly. 
TABLE I. Intracellular Distribution of Chorismate 
~~e Activity in Subcellular Fractions 
of E, coli AN58. 
-
65. 
Fri3-ction Chorismate lyase Activity 
Cell-free extract 
Large particles 
Small particles 
Supernatant, 
tE252 per h 
0.164 
0 
0 
0.167 
Cell extracts were fractionated as described by Jones 
and Redfearn (1966) in MATERIALS AND METHODS this 
section. 
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in MATERIALS AND METHODS. 
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66. 
(b) Ammonium sulphate fractionation. 
It was found that the enzymic activity precipitated 
over a broad range of ammonium sulphate concentrations. 
Therefore, it was not possible to obtain a fraction with 
greatly increased specific activity. Some fractionation 
was achieved by saturating the protein solution to 0.5 
saturation ,with solid ammonium sulphate (Figure 3.2.). 
At this saturation, one-third of the protein was precip-
itated containing 64% of the activity. More importantly 
however, the working volume was reduced from 700 ml to 
150 ml. 
(c) Batch treatment of protein with DEAE~sephadex. 
The concentrated protein solution from tne previous 
step was dialysed overnight against 0.02M Tris-HCl buffer 
(pH 8.0) containing l0- 3M EDTA, and then applied to a pad 
of DEAE-Sephadex that had been previously equilibrated 
with the same buffer. After washing the pad with the 
same buffer, the molarity of the buffer was increased to 
O.lM Tris (pH 7.0) and then to 0.2M Tris (pH 7.0). 
Pilot tests were carried out to determine which of the 
two buffer concentrations would elute the enzymic activity 
better, and also to determine whether the droo in pH would 
decrease the binding of the enzyme to the DEAE-sephadex. 
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67. 
The results of the elution of both protein and enzyr1ic 
activity from the pad of DEAE-sephadex (Figure 2.3) indicate 
that chorismate lyase binds very strongly to DEAE-
Sephadex at low molar concentration of buffer and is eluted 
slowly by 0.lM Tris-HCl (pH 7,0). The use of 0.2M buffer 
(pH 7.0) to elute the active protein gave fractions whose 
specific activity varied only a little from those obtained 
with the lower buffer concentration. 
The notable feature in Figure 3.3 is that when the 
activities of the various fractions are totalled and com-
pared to the amount of enzymic activity applied to the pad, 
then between 150% and 250% of the activity is consistently 
recovered. This result suggested that the activity increases 
at higher ionic strength and/or concentration of protein 
leads to a less active form of enzyt11e. To determine Fhich 
one of these possibilities was true, experiments were 
carried out to investiaate (i) the effect of increasina 
buffer concentration, and therefore higher ionic strenath, 
and (ii) the effect of concentrating the protein solution 
containing the enzyme. The results of Table II clearlv 
shows the effect of using high and low buffer concentrations. 
The enzyme is more active at the higher molar concentration 
of 0.lM Tris-HCl buffer (pH 8.0) containing l0- 3Ji1 EDTA. 
However, concentration o f the enzymic solution leads to a 
less rather than a more, active form of enzyme (Table III). 
The loss of activity is reversible for on dilution of the 
concentrated enzyme solution 80% of the oriqinal activity 
is regained immediately, while the remainina 20% is 
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FIGURE 3 . 3 
FRACTION 
Batch elution of orotein and chorismate 
l yase activity from a pad of DEAE-Se~hadex. 
An ammonium sulphate fraction (150 ml) was 
appl i ed to a pad of DEAE-Sephadex in 0.02M 
Tris-HCl (pH 8.0) containing l0- 3M EDTA. 
Chorismate lyase activity was eluted in 
50 ml fractions, using Tris buffer of 
varying concentrations. 
68. 
TABLE II. The Effect of Different Concentrations of 
Tris-Bu fer on Chorismate Lyase Activity. 
Bu fer Concentration 
0.02M 
0.035M 
O.OSM 
0.075M 
O.lM 
% Chorismate Lyase Activity 
60 
82 
81 
83 
100 
The purified preparation of chorismate lyase was used 
to determine the effects of different concentrations of 
Tris buffer. 
Samples of enzyme were dialysed against the different 
buffer concentrations for 24 h before determining the 
activity as described in MATERIALS AND METHODS. 
TABLE III. The Effect of Concentration of the 
Protein Solution . 
69. 
- ' Sample % Chorismate Lyase Ac~ivity 
Before Concentrati-0n 100 
After Concentration (10 fold) 65 
Dilution of concentrated 
sample (1=10) 85 
Dilution of concentrated 
sample {l:10)~ assayed 
24 hrs later 100 
* The sample used was the eluate after batch treat-
ment of the protein on DEAE-Sephadex. 
70. 
recovered when the dilu~ed elution is allowed to stand 
overnight at 4JC. 
These expe~iments indicate that when the specific 
activity of the c 10 ismate lyase preparation is low, enzy-
mic activit y is lost upon concentration, possibly due to t h e 
formation or complexes with inert protein. Another poss i b le 
explanation is that these results could be due to a 
specitic ion, namely Tr i s. Various other buffers were 
used to test this hypothesis (Table IV) . However, the 
enzyme was most active in Tris buff e r, and the effect of 
high and low buf fer c oncentrations was the same r e gard le s s 
of the buffer u s ed . 
Since he loss and g a in of activity was reproducible, 
i t was decided t o continue ~ith the p urification of the 
enzyme before undertakin f~rthe investi a~ions of the 
e fects o f ionic st ength and cor1centration on its 
activity. 
(d ) Co 1mn ch omdtography n DEA..E-Sephadex. 
Fo lowing the ba·ch treatment f the enz me on DEA 
Sephadex, fractiona ·on sin~ olumns ot )FAE and QA~-
Seph dex as atte t e e in the pJri 
QAE-Sephadex was int 
of increasing molarit, 
t j t 
x compct e about 50%. 
Although boch QAE and DEAE-Seph de eb eh cd in this 
e EAE-Sephadex did not co pac as c. as 
71. 
TABLE IV. Effect of Different Buffer Concentrations 
on Chorismate Lyase Activitv. 
Buffer 60D Chorismate Lyase 
252 
Activity at two different 
buffer concentrations. 
0.02M O.lM 
Tris-HCl-(pH 8. 0) 0.12 0.21 
N-Ethyl Morpholine-(pH 8. 0} 0.08 0.14 
TES - (pH 8. 0) 0.13 0.16 
HEPES - (pH 8.0) 0.09 0.15 
Triethanolamine-HCl-(pH 8. 0) 0.08 0.17 
The purified preparation of chorismate lyase was used 
to determine the effects of the buffers on the activity. 
The enzyme was dialysed against the different buffers before 
determining the activity as described in MATERIALS AND 
METHODS. 
72. 
QAE-Sephadex and was therefore preferred. 
The protein was adsorbed to DEAE-Sephadex in 0.02M 
. HCl b ff ( 8 0) t . ~ 10-3 d h Tris- u er pH . con a1n1nq M EDTA an t e 
column was washed with a large volume of the same buffer 
to remove unadsorbed protein. 
On increasing the buffer concentration to 0.lM the 
enzyme was slowly eluted. Therefore in order to obtain 
a sharp profile of chorismate lyase activity from DEAE·-
Se phadex, a linear gradient of Tris-buffer (0.02M - 0.2M) 
with a simultaneous pH gradient (pH 8.0 to pH 7.0) was 
used. A peak of activity coincident with a peak of 
protein was usually obtained. The active fractions were 
pooled and concentrated by ultrafiltration. 
(e) Column chromatography by gel filtration. 
(i) Agarose. 
Following chromatography on DEAE-Sephadex, Agarose o.Sm 
was successfully used. In the early stages of development 
of the purification procedure multiple peaks of protein ,,ere 
sometimes demonstrated in the fractions after passing the 
protein solution through the Agarose column (Figure 3.4) 
This suggested that aggregation could be taking place and 
that active protein was beina lost. Therefore active 
fractions from the Agarose column were combined, concentrated 
by ultrafiltration and passed alternately through Sephadex-
GS0 and Sephadex G-150 for comparison of recoveries. 
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(ii) Sephadex G-50~ 
Preliminary experiments had shown that chorismate lyase 
was a small protein of molecular weight less than 30,000. 
Therefore, it was concluded that the enzyme should be 
retarded on Sephadex G-50. However, on applying the material 
to a column of G-50 Sephadex, one major protein peak was 
obtained and this came through in the void volume, also, 
the activity and protein 6urves did not coincide (Figure 3.5). 
The total activity recovered from the column represented 
only 10% of that applied to the column. This result 
suggested aggregation of the enzyme had occurred, since the 
specific activity of the peak fraction was the same as the 
protein that had been applied to the column of Sephadex -
G-50. 
(iii) Sephadex G-100. 
The p~otein obtained after it had been passed through 
the column of Agarose in (i) was passed throug h a column of 
Sephadex G-100. One peak of protein coincident with the 
activity (Figure 3.6) was obtained. The total activity 
recovered was 95%. 
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Purification Procedure for Chorismate Lyase, 
Using the preliminary experiments described above as a 
basis for obtaining a pure protein preparation of chorismate 
lyase the following procedure was developed. The yields 
and d~grees of purification are outlined following the Purif-
ication Procedure in Table V. 
Step 1. Preparation of Crude Cell-Free Extracts. 
Cells of strain AN58 (170-lBOg; stored at -20°c) were 
thawed, suspended in 3 vol. of cold 0.1 M Tris-HCl buffer 
(pH 8.0) contai~ing l0-3M EDTA, and smashed in a Sorvall 
Ribi Fractionator at 20,000 lb/inch2 . Cell debris was 
removed by centrifuging at 17,500 x g, for 30 min at 4°C. 
All further steps were performed at o0 to 4°c, unless 
stated otherwise. 
Step 2. Removal of Nucleic Acid. 
To determine the amount of protamine sulphate required 
to remove the nucleic acid, a pilot scale experiment was 
carried out. A 2% solution of protamine sulphate in O.lM 
Tris-HCl buffer (pH 8.0) containing l0- 3M EDTA was added 
dropwise with stirring to the solution of cell-free extr act. 
The mixture was stirred for a further 30 min after the 
final addition of protamine sulphate and then centrifuged 
at 13,700 x g for 20 min. 
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Step 3. Ammonium Sulphate Fractionation. 
Finely ground ammonium sulphate (31.4g/100 ml) was 
added to the supernatant from the previous step over a 
period of 3 h. After the final addition of ammonium 
sulphate, the mixture was stirred for a further 30 min 
and then centrifuged at 13,700 x g for 15 min. The 
precipitate was redissolved in 150 ml 0.02M Tris~HCl buffer 
(pH 8.0) containing 10-3M EDTA and the protein solution 
was dialysed overnight against 4 1 of the same buffer at 
4°c. 
Step 4. Batch Elution. 
The dialysed solution from step 3 was applied to a 
Buchner funnel, containing a pad (12 x 5 cm) of DEAE-
Sephadex that had been previously equilibrated with 
0 02 . 1 b ff ( 8 0) ' . 10~3 . M Tris-HC u er pH . containing M EDTA. 
After the protein had been applied, a further 700 ml of 
the same buffer was used to wash the pad in order to remove 
the unadsorbed protein. The enzyme was eluted by allowina 
1 2 1 f O 1 . b ( ) . . 10~3 . o . M Tris-HCl uffer pH 7.0 containing M 
EDTA to slowly seep through the pad under reduced pressure. 
Care was taken to avoid frothing of the eluate, which could 
cause denaturation of the enzyme. The eluate was concen-
trated to 40-50 ml using a Diaflo ultrafiltration cell 
with a UM-2 membrane. 
Step 5. DEAE-Sephadex Chromatography. 
The concentrated solution from step 4 was dialysed 
overnight against 4 1 of 0.02M Tris-HCl buffer (pH 8.0) 
containing 10- 3M EDTA, and then applied to a column 
(2 x 40 cm) of DEAE-Sephadex equilibrated with the same 
buffer. The column was then washed with sufficient 
buffer (usually 500 ml) to remove all unadsorbed orotein 
Elution of the enzyme was carried out with a linear gradient 
of Tris buffer (0.02M - 0.2M), with a simultaneous pH 
gradient (pH 8.0 to pH 7.0), in a total volume of 500 ml 
(Figure 3.7). The active fractions were pooled and on-
centrated by Diaflo ultrafiltration to a volume of approx-
imately 5 ml. 
Step 6. Gel Filtration on Agarose. 
The concentrated solution from step 5 was dialysed 
against 2 1 of 0.1 M Tris-HCl buffer (pH 8.0) containing 
l0- 3M EDTA, and applied to a column (1 x 136 cm) of Agarose 
equilibrated with the same buffer. The enzyme was eluted 
with the same buffer and the active fractions were pooled 
and concentrated by Diaflo ultrafiltration, to a volume of 
approximately 5 ml (Figure 3.8). 
Step 7. Gel Filtration on Sephadex G-100. 
When more than one peak of protein was obtained from 
the Agarose column, it was necessary to apply the protein 
to Sephadex G-100. This was done to ensure that there was 
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only one peak of protein, which was coincident with the 
activity. 
Under these circumstances the protein obtained from 
step 6 was dialysed against 2 1 of 0.lM Tris-HCl buffer 
(pH 8.0) containing l0- 3M EDTA and applied to a column 
(1 x 100 cm). The enzyme was eluted with the same buffer 
and the active fractions were pooled, and concentrated by 
Diaflo ultrafiltration to approximately 5 ml. 
The purified enzyme preparation was stored at 4°c 
until required and remained stable for at least two weeks. 
TABLE V. Purification of Chorismate Lyase From E.coli K-12.-
~ummary of yields and degrees of purification. 
Procedure Vol. Activity Total Units Total Spec·ific Purific- Yield (ml) (uni.ts/ml) Protein Activity ation. (%) 
(mg) ( units 
mg) 
Crude extract 550 3.5 1,925 16,'775 0.11 1 100 
Supernatant 800 2.6 2,080 11,440 0.18 2 108 
after precip-
itation of 
nucleic acid. 
0-0.5 Sat. 150 4.8 720 3,075 0.23 2 37 (NH 4 ) 2so 4 ppt. 
assayed after 
dialysis. 
Eluate from Batch 
treatment on 
DEAE-Sephadex 
1. before concn.1200 1.14 1,368 398 3.43 30 71 
2. after concn. 40 6.8 272 398 0.68 6 14 -...J co 
,. 
DEAE-Sephadex 56 0.91 51 16 3.3 28 3 
column 
Agarose column 4 6.33 25 7 3.6 33 1 
79 . 
DISCUSSION. 
The development of the purification procedure for 
chorismate lyase was very time consuming, especially in 
the early stages, because of the complex behaviour of the 
enzyme. Further, the low concentration of enzymic 
activity in crude extracts made the task of obtaining a pure 
preparation a difficult one. Many different assay proced-
ures were tried in the early stages of . the purification, 
but failed due to (i) the presence of other contaminating 
enzymes or (ii) the mixture of products obtained from the 
chemical decomposition of the substrate, chorismate. 
These technical difficulties were avoided by the use of a 
spectrophotometric assay for 4-hydroxybenzoate, even though 
this was a time consuming method. 
The apparent inexplicability of a large number of the 
initial observations was almost wholly due to aggregation 
I 
or association of chorismate lyase with other inert protein. 
These effects complicated the interpretation of results 
very markedly during the purification procedure, and made 
it very difficult to place much confidence in the results 
obtained until the system was more clearly understood. 
From the results showing the degree of purification and the 
yield of the pure protein preparation (Table V), the values 
for the specific activities do not increase in magnitude 
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step by step, as would be expected. This is particularly 
noticeable before and after concentration of the eluate 
from the batch treatment of protein on DEAE-Sephadex, 
where the specific activity decreases and then increases 
again after concentration. This is explained by the 
previous observation of the effect of concentration of 
the enzyme solution (Table III). 
The enzyme preparation usually showed a constant 
specific activity after the Agarose column. If this was 
not so, the active fractions from the Agarose column were 
combined, concentrated and passed through a column of 
Sephadex G-100 in order to obtain such a preparation. 
The enzyme preparation was stored at 4°c and maintained 
the same specific activity for a period of at least two 
weeks. 
Due to the possibility that aggregation of chorismate 
lyase could cause grossly inaccurate values in degrees 
and yields of purificati·on (Table V) the amount of enzyme 
in the cell has not been given. 
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SECTION 3.2. PROPERTIES OF CHORISt~ATE LYASE. 
81. 
INTRODUCTION. 
One of the aims of the present work was to determine 
whether the enzyme had a high or low turnover number. 
Coupled with this, the general p r operties of chorismate 
lyase were also investigated with a view to f u r ther under-
standing the functional characteristics of the enzyme. 
In the previous section, details of the pur ification 
procedure are given and as a continuation to this, the 
homogeneity of the protein preparation is established. 
The behaviour of chorismate lyase on polyacrylami de gels, 
in BM urea, and in sodium dodecyl sulphate is described . 
The homogeneity o f the protein preparation is established 
using the criteria of ultracentrifugation and polyacrylamide 
gel ~lectrophoresis. The molecular weight of the prot ein 
preparation is determined by gel filtration and sediment-
ation equilibrium experiments, together with amino acid 
analysis and peptide maps. 
Lastly, some of the kinetic parameters are determined 
and an attempt to draw some conclusions as to the possible 
mechanism of the reaction is made from these results. 
82. 
MATERIALS AND METHODS. 
Chemicals. 
Chemicals generally were of the highest purity 
obtainable commercially and were not further purified. 
Iodoacetamide was purified by recrystallisation 
from ethyl acetate-petroleum ether and stored in the 
dark until used. Barium prephenate was prepared by 
Dr. R. Ghambeer, and chorismate was prepared by the 
method of Gibson (1968). 
Determination of Enzyme Activity. 
The conversion of chorismate to 4-hydroxybenzoate 
and pyruvate was measured in two ways:-
(i) Initial rates for the conversion were measured by 
stopping the reaction at fixed time periods, followed by 
spectrophotometric estimation of 4~hydroxybenzoate. The 
reaction mixture contained 1.66 mM chorismate, 0.4 rru~ EDTA, 
chorismate lyase ("v200 µg protein) and 40 mM Tris-HCl 
buffer (pH 8.0), in a final volume of 1.0 ml. The blank 
consisted of all the reactants except the enzyme. After 
incubation at 37°c for a specific time period, the 
reaction was terminated by the addition of 0.5 ml of 
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0.2M sodium acetate buffer (pH 4.0). 4-Hydroxybenzoate 
was extracted into ether, (5 ml}, which was dried over 
anhydrous sodium sulphate before determination of absorb-
ency on a Model 15 Cary Spectrophotometer from 360-240 nm. 
The amount of 4-hydroxybenzoate formed was calculated using 
a molar extinction value of 16,400 in ether, at 252 nm. 
(ii) Initial rates for the reaction were measured contin-
uously in a Cary 14 Recording Spectrophotometer in the 
presence of the coupled enzyme system of lactate dehydrog-
enase/NADH. The amount of pyruvate formed was measured 
by the disappearance of NA.DH at 340 nm. The reaction 
mixture for the inhibition studies consisted of 1 to 10 
mM chorismate, 0.4 m.M EDTA, 50 µl chorismate lyase 
(~200 µg protein), 0.1 mM NADH, 5 µg lactate dehydrogen-
ase, and 250 mM N-Ethyl Morpholine-HCl buffer (ph 8.0) , 
in a final volume of 1.0 ml. The blank consisted of all 
the reactants except the enzyme. 
Where inhibitors and various analogues were added, the 
volumes and concentrations of other components remained 
unaltered. The reaction mixtures were preheated at 
37°c in a cuvette in the heated compartment of the Cary 
Model 14 spectrophotometer and the reaction was commenced 
by the addition of enzyme solution. The amount of NAD 
formed was calculated using a molar extinction co-
efficient of 6,220 (Dawson et al. 1969). 
84. 
Methods of Analysis of Kinetic Data5 
The calculations of the Michaelis-Menten constant 
Km, the maximal velocity and inhibitor constant, Ki, 
were done using two programs provided and calculated by 
Dr. J.F. Morrison. The programs were based on the method 
of minimisation of the sum of the squares of the distances 
of the points from . the line. 
Equation (1) was V - V 
1 + Km - s 
and Equation (2) was V - V 
1 + Km (1 + i ) 
- s Ki 
Polyacrylamide Gel Electrophoresis. 
Polyacrylamide disc gel electrophoresis was carried 
out using essentially the same method as that described 
by Davis 1964), except that the stacking and sample gel 
were eliminated. The sample in O.lM Tris-HCl buffer 
(pH 8.0) containing 10- 3 M EDTA and 40% sucrose was 
applied directly to the top of the resolving gel. The 
two buffer systems used were Tris-glycine in the range 
from pH 9 to pH 10 (Davis, 1964) and the Triethanolamine 
(TEA) - TES-chloride system in the range pH range 7-8 
(Orr, 1969). Bromophenol blue was added to each gel and 
0 
runs were made at 4 Cat 2.5 mA/tube. Protein was 
detected by staining the gel with Arnido Black in acetic 
acid (Davis, 1964). 
Gel Electrophoresis using Sodium Dodecyl Sulphate. 
Protein was denatured by the method of Weber and 
Osborn (1969), which uses sodium dodecyl sulphate. 
Protein solutions were dialysed overnight at room temp-
erature against 0.0lM sodium phosphate buffer (pH 7.0) 
containing 0.1% sodium dodecyl sulphate. The samples 
( ~100 µg) were then electrophoresed in either 7.5% 
or 10% gels at room temperature with a constant current 
of 4mA/tube. The_ gels contained 0.2% sodium dodecyl 
sulphate. Protein was stained as described above. 
Electrophoresis in BM urea. 
Electrophoresis of proteins in polyacrylamide gels 
containing BM urea was carried out using the Tris-
glycine buffer pH 9.0 - 10.0 of Davis (1964). 8M urea 
was added to 10% gels before polymerisation and the 
samples were also prepared in 8M urea. 
Ultracentrifugation. 
Sedimentation velocity runs were used to establish 
the purity of the enzyme preparation. These were carried 
out in the Model E Analytical Ultracentrifuge at 60,000 
revolutions per min in aluminium-filled capillary-type 
synthetic boundary cells at a temperature of approxim-
o 
ately 21 C. 
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To deterrine the approximate molecular weight, 
Mapp., equilibrium ultracentrifugation was used. The w 
conditions were calculated according to the scheme of 
Howlett and Nichol (in press) o The plates were measured 
and the results computed using a program of G. Howlet 
which was based on the method of Richard, Teller, and 
Schachman (1968) . The ultracentrifugation work to 
determine the molecular weight of chorismate lyase was 
performed by Dr.A.B. Roy of the Department of Physical 
Biochemistry, Australian National University. 
Gel Filtration and Molecular_~~ight Determination. 
The molecular weight of chorismate lyase was 
determined by gel filtration according to the method of 
Andrews (1964, 1965) using a column of Sephadex G-100 
l x 00 cm) equilibrated with O.lM Tris-HCl (pH 8.0) 
burfer containing 10-JM EDTA. Samples of the standard 
protein sol tion (10 mg/ml) were applied to the column 
in 1 ml volumes of the same buffer. Fractions were 
collected and the exact volume in each fraction was 
measured by weighing each tube before and after the 
samples were run. 
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Peptide Mapping. 
The purified enzyme (2 mg) was hydrolysed by trypsin 
(1% w/w) in aqueous ammonium bicarbonate solution (0.5%) 
pH 8.0 at 37°c for 2 h after which time a further aliquot 
of trypsin (1% w/w)was added and hydrolysis was continued 
for a further 2 h; to destroy any chymotryptic activity, 
trypsin was allowed to stand in ice in 0.01M hydrochloric 
acid for½ h before use. The ammonium bicarbonate was 
removed by lyophilisation, and the hydrolysate was dis-
solved in a small volume of water (approximately 20 µl) o 
The soluble peptides were applied to a sheet of Whatman 
3MM paper and subjected to high voltage electrophoresis 
in pyridine-acetic acid buffer at pH 4.7, in tanks 
designed after Michl (1958), using varsol (mineral turp-
entine) as heat exchanger. The buffer system contained 
25 ml pyridine and 25 ml glacial acetic acid in 1 t 
(Schwartz, 1963). 
After the electrophoretograms had been dried at 
room temperature, the strips of paper containing the 
separated peptides were sewn onto fresh sheets of paper 
(Milstein and Sanger, 1961) and then chromatographed 
in the second dimension using n-butanol: acetic acid: 
water (4:1:5 by vol., upper phase only; Katz 7 Dreyer and 
Anfinsen, 1959) or pyridine: isoamyl alcohol: water 
(7:7:6 by vol.; Wittman and Braunitzer, 1959). During 
the preparation of the peptide maps for chorsirnate 
lyase, B-lactoglobulin was run as a control. 
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Each chromatogram was sprayed with ninhydrin 
reagent (0.1% w/v ninhydrin in acetone, containing 0.2% 
v/v glacial acetic acid and 0.2% v/v pyridine), and 
stored in the dark for 24 h to allow colour develop-
ment. The chromatograms were photographed and the 
ninhydrin-positive areas were marked with pencil before 
decolourisation with chlorine. Larger peptides and in 
particular the 'core' material which does not stain well 
with ninhydrin, were detected after chlorination by 
starch-iodide (Rydon and Smith, 1952). 
Preparation of Dansyl Peptide Maps. 
Twice recrystallised trypsin (1%) was treated with 
~ 6 hydrochloric acid for 24 hat 37°c (Redfield and 
Anfinsen, 1956), and then dialysed against cold water for 
24 h before being lyophilised. Tryptic digestion was 
carried out in O.lM sodium bicarbonate (pH 8.0), using 
5% (w/w) of trypsin for 2 hat 37°c. The tryptic digestion 
mixture was then added dropwise to an equal volume of a 
solution of 'dansyl' chlordie (twenty-fold excess) in O.lM 
sodium bicarbonate and acetone (1:1 by vol.; Atherton 
and Thomson, 1969). The resulting mixture was left to 
stand at room temperature overnight before applying to a 
column of Dowex 50 x 8 (1 x 2 cm) previously equilibrated 
with O.OlM acetic acid. The column was washed with 600 ml 
of O.OlM acetic acid before eluting the peptides with lM 
89. 
ammonia in 25% aqueous acetone (v/v). The eluant, con-
taining fluorescent material, was concentrated by rotary 
evaporation. The sample containing the peptides was 
dissolved in a minimum vblume of 90% aqueous tetrahydro-
furan (v/v) be£ore applying to a thin layer silica gel 
plate (20 x 20 cm; 2.5 mm thick) and developing in a 
two dimensional chromatographic system. Solvent 1 (first 
dimension) consisted of methyl acetate:propan-2-ol:aqueous 
NH 3 (9:t:4 by vol.; Seiler and Wiechmann, 1964), and 
solvent 2 (second dimension) consisted of chloroform~ 
95% ethanol: acetic acid (38:4:3 by vol.; Deyl and Rasmus 
19 65} • 
Amino Acid Analysis. 
The protein samples were hydrolysed in sealed evacuated 
tubes in 6M HCl at 110°c for 22 h (Crestfield, Moore and 
Stein, 1963). The hydrolysates were analysed essentially by 
the method described by Spackman, Stein and .Moore (1958) 
using a Beckman Model 120B amino acid analyser. Half 
cysteine was determined as cysteic acid after performic 
acid oxidation of the protein (Hirs, 1956). Tryptophan 
was not estimated. 
90. 
Identification of the Reaction Products. 
The conversion of chorismate to 4-hydroxybenzoate 
was established by Gibson and Gibson (1962). The other 
product which was derived mechanistically from this 
reaction, was established by (i) chromatography and 
(ii) a coupled enzyme system using NADH and lactate 
dehydrogenase. The reaction mixture consisted of 4 mM 
chorismate, 90 mM Tris-HCl buffer (pH 8.0), 0.9 mM EDTA 
and 200 µg chorismate lyase in 1.0 ml. The control con-
sisted of all the reactants except the enzyme~ The re-
action was incubated at 37°c for 4 hand terminated in the 
usual way by the addition of 0.5 ml 0.2M sodium acetate 
buffer (pH 4.0). The 2,4 dinitrophenylhydrazone deriv~ 
ative of the product formed was prepared by the method of 
Neuberg, Grauer and Pisha (1952) and chromatographed and 
developed on thin layer plates of silica gel in benzene: 
~etrahydrofuran: acetic acid (60:36:4 by vol.; Byrne, 
1965). 
Stoichiometry of- the Reaction. 
Estimation of the amount of 4-hydroxybenzoate formed 
was determined by the normal spectrophotometric method 
used previously, while pyruvate was estimated spectra-
photometrically at 340 nm using the coupled enzyme system, 
lactate dehydrogenase and NADH. Samples were taken at 
91. 
various time intervals in order to determine when equil-
ibrium was established. When estimating 4-hydroxybenzoate, 
the reaction was terminated by adding the sample to 0.5 ml 
0.2M sodium acetate buffer (pH 4.0). The aliquot (0.1 ml) 
for the est imation of pyruvate was diluted 10 fold which 
effectively terminated the reaction. 
P~tein D€termination. 
The protein concentration in samples of purified 
enzyme was obtained spectrophotometrically by determining 
the absorpt ion coefficient at 280 nm of a 0.1% solution 
(w/v). The absorption coefficient was calculated to be 
1.40. 
92. 
RESULTS. 
' Honrogene'i.ty of the Purified Enzyme. 
(a) Ultracentrifugation. 
I 
Ultracentrifugation of the enzyme gave a single 
symmetrical peak which suggested that it was a homogeneous 
preparation (Figure 3.9). An s20 value of 2.0 was 
obtained using buffer concentrations of 0.1 and 0.0lM. 
Although an 
differ from 
s0 value is not available, it would not 20 ,w 
the s20 value by more than 5%. As the 
so 
20 ,w 
for lysozyme (molecular weight .14,000) is approximately 
i.87,the estimated S value for chorismate lyase would 20 
suggest a molecular weight of about 15,000. 
(b) Polyacrylamide Gel Electrophoresis. 
When the gels were run in two different buffer 
systems, namely in the system described by Davis (pH 9-1 0 ) 
(1964) and the system described by Orr (pH 7-8) (1969 ), 
multiple bands of protein were always seen (Figure 3. 10 ). 
These consisted of three major bands together with a 
number of minor bands. However, on t reat i ng 
the protein with sodium dodecyl sulphate, as described by 
Weber and Osborn (1969), one band of protein was obtained 
(Figure 3.10). Since sodium dodecyl sulphate reacts with 
8 
FIGURE 3. 9 
16 min 24 min 
The sedimentation pattern of purified 
chorismate lyase protein. The enzyme 
concentration was 2.7 mg per ml in a 
medium of 0.0SM NaCl and 0.0SM HCl 
buffered at pH 8.0 with Tris. 
Photographs were taken at 8 min intervals 
and an s20 value of 2.0 suggested a 
molecular weight of ~15,000. 
FIGURE 3.10 Polyacrylamide gel electrophoresis of ~100 µg 
samoles of chorismate lvase : 
... .,. 
A. run in Tris-glycine (pH 9.0 - 10.0) 
B. run in Tris-glycine in the presence of 
0.1% sodium dodecyl sulphate 
c. run in TES-TEA (pH 7.0 - 8.0) 
D. run in a completely deuterated system 
using Tris-glycine buffer. 
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protein and overcomes charge effects, movement of protein 
in gels depends only on its molecular weight. The be-
haviour of the protein on normal gels could suggest the 
presence of isoenzymes with different charges. Other 
denaturating agents were tested and their effects noted. 
Urea, in concentrations ranging from 2 to 8M was used; 
however, multiple bands still appeared (Figure 3.1 ~ . The 
effect of hydrogen bonding as a possible explanation for 
these obs~rvations was investignted. The protein was 
dialysed against D2o and electrophoresed in a completely 
deuterated system. However, as illustrated in Figure 3.10, 
multiple bands were still obtained. Although various 
other compounds were added to the gels to determine if the 
number of bands could be reduced, only sodium dodecyl 
sulphate yielded the one band. Potassium chloride, and 
4-aminobenzoate were without effect, while potassium 
cyanate yielded a reduced number of bands. 
Since the gels were run in a discontinuous system, 
the gradient change in pH along the gel could be respons-
ible for the multiplicity of bands. In fact, Orr (1969) 
observed similar effects with ribonucleotide reductase.. 
After considerable effort varying both the concentratio s 
of the gel components and the composition of the buffer, 
he was able to obtain a single band of protein. 
It was the effect of sodium dodecyl sulphate in gels 
that indicated the preparation of chorismate lyase was 
purified to homogeneity. 
A 
FIGURE 3.10a 
--
B C D E 
Polyacrylamide gel electrophoresis using 
different concentrations of urea. 
Samples of chorismate lyase were treated 
with urea and then electrophoresed in 
gels containing different concentrations 
of urea : 
A. 2 M; B. 4 M; C. 6 M; D. 8 M; 
E. no urea. 
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Molecular Weight Determinations. 
The molecular weight of chorismate lyase was de-
termined by two methods. The first procedure was that of 
Andrews (1964, 1965J, which involved the use of standard 
proteins to determine the elution volume with respect 
to molecular weight. Chorismate lyase was shown to have 
a molecular weight of 15,800 which is relatively small 
(Figure 3.11). This method is inaccurate in the determ-
ination of the elution volumes of proteins of low molec-
ular weight i.e~ from 12,500 to around 20,000. In this 
region, pro teins are retarded on Sephadex G-100, but give 
broad peakS • Thus inaccuracies in the determination of 
the elution volume arise. 
The molecular weight was also determined by equil-
ibrium ultracentrifugation, which gives an approximate 
value by measuring the molecular weight at various con-
centrations of protein. Hence, a range of molecular 
weights is obtained. For a pure non associating-dissociat-
ing system, only one value is obtained. However, in the 
present case, a range of molecular weights was obtained 
ranging from a value of approximately 13,000 at the men cu s 
to 39,000 at the base of the cell (Figure 3.12). The con-
clusions that may be drawn from this are (i) that the 
protein is inhomogeneous or {ii) the protein is undergoing 
association-dissociation under these conditions. This 
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Estimation of the molecular weight of 
chorismate lyase by gel filtration on 
Sephadex G-100. The proteins us e d, 
together with their molecular weights, 
are shown below : 
1 . ribonuclease 12,500 
2 . chorisroate lyase 15,800 
3 . myoglobin 17,000 
4 . ovalbumin 45,000 
5 . serum albumin monomer 67,000 
6. serum albumin dimer 134,000 
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Esti~ation of the molecular weight of 
chorismate lyase by eauilibrium centri-
fuqation. The results are from two 
different estimations and are plotted 
together. Cr is the concentration of 
protein measured by displacement fringes, 
and extends over a range from ~1 mg per 
ml at the meniscus to ~4 mg per ml at the 
b f th 11 ~.~app th ase o e ce . n is e approx-wr 
imate molecular weight. 
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second conclusion is in accord with the data obtained 
from the gels. However, to establish that chorismate 
lyase is an associating-dissociating system under these 
conditions, it would be necessary to carry out experim-
ents at different temperatures, pH, ionic strengths and 
protein concentrations. This aspect of the work was 
not pursued further as the amount of enzyme available 
precluded such an extensive investigation. A molecular 
weight of 15,800, as estimated by the method of Andrews 
(1964, 1965), was therefore taken to be the molecular 
weight of chorismate lyase. This value was used in the 
calculations of the number of amino acid residues and 
the turnover number of chorismate lyase. 
Peptide MapEing and Amino Acid ~alysis. 
< 
Conventional peptide mapping procedures were in-
itially used. These involve a two dimensional separation 
on paper of a tryptic digest of the protein. Although 
these methods usually permit clear separation of the pep-
tides into discrete spots, this was not the case in either 
of the solvent systems used, (Figure 3.13 and 3.14). 
Therefore, the dansylation technique employed by Atherton 
and Thomson (1969) was used to determine if separation of 
the 'dansylated' peptides could be obtained. This method 
has many advantages in comparison with conventional peptide 
methods, the most important of which is the small quantity 
FIGURE 3.13 Peptide map of chorismate lyase 
from E. coli. 
First dimension: Electrophoresis in 
pyridine acetate pH 4.7, 50 volts per 
cm for 2 h. 
Second dimension: Chromatography in 
butanol:acetic acid:water (4:1:5, by 
vol., top phase). The map was stained 
with ninhydrin to show the peptides 
present. 
. . . , ., ...... , .............. . 
FIGURE 3 .14 Peptide map of chorismate lyase 
from E. coli. 
First dimension: Electrophoresis in 
pyridine acetate pH 4,7, 50 volts per 
cm for 2 h. 
Second dimension: Chromatography in 
py~idine:isoamyl alcohol:water (7:7:6, 
by vol.). The map was stained with 
ninhydrin to show the presence of 
peptides. 
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of material that is required for each map. Another advant-
age is that the protein is made more hydrophobic which 
enables the peptides to be separated with organic solvents. 
There is non-specific staining of peptides when ninhydrin 
staining procedures are used, compared to the use of 
dansylated peptides which are each chemically reacted with 
the reagent before the map is developed. The results in-
dicated that tryptic digestion gives rise to approximately 
14 to 18 peptides (Figure 3.15). 
Some criticism of the 'dansylatedt method may be 
mentioned, in that very close to the origin it is difficult 
to determine the absolute number of peptides, as there 
appears to be a considerable amount of fluorescent material. 
To the naked eye, this area contains more discrete spots 
than is indicated by the photograph, so a diagram of the 
same chromatogram is included (Figure 3.16). In comparison 
to the number of peptides seen in the 'dansylated' peptide 
map, the number of peptides that theoretically are 
obtained from the amino acid composition (Table VI) is 
approximately 13. This estimation of the number of pep-
tides is determined from the number of lysine and arginine 
residues calculated for a molecular weight of 15,800 for 
chorismate lyase. Since chorismate lyase is a single poly-
peptide chain, then each of the residues lysine and arginine 
would be present in a unique sequence. The total number of 
tryptic peptides on the fingerprints would be given by: 
Total number of lysine and arginine residues plus one. 
FIGURE 3.15 Photograph of a 'dansylated' peptide map 
of chorismate lyase, taken through a 
yellow filter. The origin is in the 
bottom left hand corner. 
First dimension: Developed in methyl 
acetate:propan-2-ol:aqueous ammonia 
( 9 : 7 : 4 , by VO 1 . ) . 
Second dimension: Developed in 
chloroform:95% ethanol:acetic acid 
( 3 8 : 4 : 3 , by VO 1 . ) . 
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A diagrammatic representation of 
Figure 3.15, with the by-products 
of the reagent indicated by shaded 
spots. Very faint soots have been 
omitted. 
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TABLE VI. Amin~Acid_Composition of Chorismate Lyase, 
Amino Acid 
Lysine 
Histidine 
Arginine 
Aspartic Acid 
Threonine 
Serine 
Glutamic acid 
Praline 
Glycine 
Alanine 
Valine 
Methionine 
Isoleucine 
Leucine 
TyrosineC 
Phenylalanine 
Tryptophana 
Cysteine d 
Number of Residues calculated 
for a molecular weight of 15,800. 
Average of Two 
Determinations 
6.9 
1.3 
3.8 
12.4 
6.6 
6.6 
13.5 
6.8 
17.5 
17.1 
11.3 
3.1 
6.2 
11.2 
2.0 
3.3 
Performic acid 
oxidised sample. 
7.9 
0.9 
3 .. 4 
13.5 
7.0 
7.0 
14.2 
5.6 
18.4 
18.2 
11.3b 
3.1 
6.2 
10.7 
1.9 
0.6 
a. Tryptophan was not estimated. 
b. Methionine was estimated as methionine sulphone 
and d. cysteine was estimated as cysteic aciu 
in the performic acid oxidised sample. 
c. Tyrosine was destroyed after performic acid 
oxidation 
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It is to be noted in the amino acid analysis that 
thee is only one residue of cysteine per molecule of 
chorismate lyase. The lack of involvement of the - SH group 
in the activity of the enzyme is confirmed later in this 
section when the activity of the enzyme is shown not to be 
affected by the sulphydryl reagents, iodoacetamide and 
N-ethylmaleimide. The larger number of peptides obtained 
on the peptide map could be explained by artifacts either 
arising from the tryptic digest or from excess fluores-
cence on the chromatogram. This latter comment would 
require that analysis of the 'dansylated' peptides be 
carried out in order to determine that all fluorescent 
spots were peptides derived from chorismate lyase. 
Identification of the Reaction Products. 
The conversion ot chorismate to 4-hydroxybenzoate 
was established by Gibson and Gibson (1962). The estab-
lishment of pyruvate as the second reaction product is 
shown in Figure 3.17. The chromatogram of the 2,4 di-
nitrophenylhydrazone derivative of pyruvate is obtained 
from the reaction mixture of chorismate and chorismate 
lyase. This derivative co-chromatographed with the syn-
thetic 2,4 dinitrophenylhydrazone derivative of pyruvate. 
Further, the evidence of the coupled enzyme system, 
A 
FIGURE 3.17 
B C D 
Chromatography on silica-gel plates of 
the -2 , 4-dinitrophenylhydrazone 
derivative of pyruvate. 
A. 2,4-dinitrophenylhydrazone 
synthetic derivative of pyruvate. 
B. reaction mixture treated with 
2,4-dinitrophenylhydrazine. 
C. control blank for the reaction 
treated with 2,4-dinitrophenyl-
hydrazine. 
D. reaction mixture co-chromatographed 
with the 2,4-dinitrophenylhydrazone 
synthetic derivative. 
E. 2,4-dinitrophenylhydrazone 
synthetic derivative of pyruvate. 
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lactate dehydrogenase and NADH, also establishes one of 
the products of the reaction as pyruvate. In this 
connection it should be mentioned that 4-hydroxybenzoate 
is not a substrate for the reaction. The only other 
product must therefore be a ketone product. 
Stoichiometry of the Reaction. 
The amount of each product formed from chorismate 
by chorismate lyase was determined by the normal spectro-
photometric methods. 4-Hydroxybenzoate and pyruvate are 
formed in equimolar amounts {Table VII). Since the amount 
of pyruvate formed is equivalent to the amount of 4-
hydroxybenzoate formed from chorismate, initial rates of 
the reaction were thereafter measured using the pyruvate 
assay. 
Equilibrium Constant Determination. 
The equilibrium constant for the reaction was 
determined using the coupled enzyme system, and calcu-
-5 lated to be 2.7 x 10 M from two experiments. 
Time Course of the Rea~tion. 
The rate of the reaction converting chorismate to 
4-hydroxybenzoate and pyruvate begins to fall off after 
10 min, and equilibrium is reached after 1 h (Figure 3.18). 
100. 
TABLE VII. Determination of the Stoichiometry of 
the Reaction. 
Time 
(min) 
0 
1 0 
20 
30 
60 
90 
120 
150 
180 
Concentration of 
Pyruvate formed 
µmoles per ml) 
0 
0.015 
0.047 
0.078 
0.141 
0.203 
0.287 
0 .328 
0 .323 
Concentration of 
4~hydroxybenzoate 
formed (µmoles per mll 
0 
0.10 
0.040 
0.060 
0 . 154 
0. 211 
0. 298 
0. 315 
0.320 
The reaction mixture consisted of 4.0 mM chorismate, 
600 µg chorismate lyase, 5 µg lactate dehydrogenase, 
0.1 mM NADH in a total volume of 1.0 ml. The appropriate 
blank was used and estimation of pyruvate and 4-hydroxy-
benzoate was carried out as described in MATERIALS AND 
METHODS. 
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Time course of the reaction catalysed by 
chorismate lyase, as measured by the 
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see MATERIALS AND METHODS. 
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When the substrate concentration was 1 mM or higher, 
and the enzyme concentration was relatively high (200 µg 
protein per ml reaction mixture), initial rates could be 
successfully measured in the kinetic experiments. 
pH Optimum Determination. 
The pH optimum was determined under conditions 
where lactate dehydrogenase was in excess at all pH 
values. The results (Figure 3.19) indicate that the 
optimum pH value for the conversion of chorismate to 
4-hydroxybenzoate and pyruvate is pH 8.0. Since NADH 
and lactate dehydrogenase were present in excess, the 
sharp rise and fall of the pH curve is a true indication 
of the optimum chorismate lyase activity. 
Effect of Salt Concentration on Activity. 
The addition of increasing salt concentration to 
standard reaction mixtures resulted in an initial marked 
activation of the enzyme, and this was then followed by 
its inhibition. Optimum activation was obtained at a 
salt concentration of 0.3M (Figure 3~20). The results 
may be compared with those obtained earlier (Section 3.1), 
where an increase and decrease in enzymic activity was 
observed when the ionic strength of the buffer was 
raised and lowered respectively. 
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Effect of Temperature on Activity. 
After exposing the enzyme to the various temper~ 
atures for 30 min, the esidual activity was determined. 
The enzyme is quite stable at low temperatures up to 37°c, 
and is also sightly ac ivated at these temperatures 
Figure 3.21). Activity is rapidly lost at higher temp~ 
0 
eratures, and incubation of the enzyme at 45 C resulted 
in the precipitation of the protein. 
Effect of Enzyme Concentration on the Reaction Velocity. 
The results of Figure 3.24 indicate that there is a 
linear relationship between the initial velocity of the 
reaction and the concentration of protein at two different 
substrate concentrations. These data suggest that a 
forty-fold increase in enzyme concentration from 5 to 
200 g/ml does not result in polymerization of the enzyme 
to a less or more active form, or alternatively that 
polymeric form(s) of the enzyme possess the same specific 
activity. Therefore, no comp ications arise in the 
kinetic investigations. 
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Effect of Chorismate Concentration on the Reaction Velocity. 
Figures 3.22 and 3.23 show the effect of varying 
chorismate concentration on enzymic activity. There is 
some difficulty in obtaining accurate data below substrate 
concentrations of 1 rnM, because the reaction velocity is 
too low. When the data of Figure 3.22 were plotted in 
double reciprocal form, a linear curve was obtained 
(Figure 3.23) . Thus it may be concluded that the reaction 
conforms to conventional Michaelis~~enten kinetics. 
Michaelis constant (Km) was calculated from the results 
+ in Figure 3.23 to be 0.10 - 0.04 rnM. The maximum 
velocity was calculated from these same results to be 
+ 6.8 - 0.1 nmoles/per min per mg protein. 
Effect of 4-Hydroxybenzoate Concentration on the 
Reaction Velocity. 
The linear competitive inhibition of the enzyme 
reaction by 4-hydroxybenzoate is illustrated in Figure 
3.25, and it will be noted that considerable inhibition 
is observed in the presence of relatively low concent-
rations (0.0SmM and 0.1 mM) of 4-hydroxybenzoate. The 
data were fitted to equation (2) and a value of 
6 ± 2 µM was obtained for the inhibition constant (Ki). 
The ratio of Km for chorismate: Ki for 4-hydroxybenzoate 
+ was calculated to be 17.8 - 1.0 from which it may be 
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concluded that 4-hydroxybenzoate is a potent inhibitor of 
the reaction. Since this product acts as a linear com-
petitve inhibitor it follows that both chorismate and 
4-hydroxybenzoate raect at the same site on the enzyme. 
Effect of Pyruvate Concentration on the 
Reaction Velocity. 
Concentration of pyruvate up to 20mM had only a 
negligible inhibitory effect on the reaction velocities 
over a range of chorismate concentrations (Figure 3.26). 
At a pyruvate concentration of 100 mM a slight activation 
was observed and this could possibly be due to the in-
crease in ionic strength (cf. Figure 3.20). 
Effect of Chemical Reagents on Enzymic Activity. 
The effect of chemical modifying reagents on the 
activity of the enzyme is shown in Table Vlll. The range 
of concentrations that were used to observe effects on 
chorismate lyase activity was from 1 mM to 0.01 mM. Table 
Vlll shows the results of the various reagents used. 
Iodoacetamide and N-ethylmaleimide had no effect on chor-
ismate lyase activity although not all sulphydryl groups 
react with iodoacetamide, they nevertheless will, if 
present, react with N-ethylmaleimide at a concentration 
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FIGURE 3. 26 The effect of pyruvate, using a concen-
tration of 20 mM, on chorismate lyase 
activity, as shown by the double recip-
rocal plot. Initial rates for the 
reaction were measured by the NADH/ 
lactate dehydrogenase assay. 
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TABLE VIII. Effect of Various Modifying Reagents on 
The Activity of Chorismate Lyase. 
Modifying 
Reagent. 
Iodoacetamide 
N-ethylmaleimide 
Tetranitromethane 
N-bromoeuccinimide 
Concentration 
l.OmM 
1-. OmM 
l.0mM 
0.lmM 
l.0mM 
O.lmM 
Residual Activity 
(%) 
100 
100 
48 
92 
31 
96 
The conditions for determining the effects of these 
reagents were the same as those for 4-hydroxybenzoate 
estimation as described in MATERIALS AND METHODS. The 
protein was pre-incub~ted for 30 min at 37°c in the 
presence of modifying reagents before assaying for activity. 
10 6. 
of 1.0 mM. The chemical reagent 1.0 mM tetranitrome hane 
is effective in destroying 52% of the activity while 
N-bromosuccinimide is effective in destroying 69% of the 
ac ivity of chorismate lyase. 
Effects of Analogues and Allosteric Modifiers on the 
Reaction. 
Va ious compounds which could be considered as 
analogues o both chorismate and 4-hydroxybenzoate were 
used over the concentration range of 0.01 mM to 1.0 mM 
to dete mine whether they were able to function as in-
hibitors of chorismate lyase. The results are shown in 
Table IX. Those compounds which greatly affect chorismate 
lyase activity are 3,4-dihydroxybenzoate (t O mM) and 
2,5-dihydroxybenzoate (0.1 mM) where the activity is 
reduced to zero at the concentrations used. These 
results suggest that the hydroxyl group is involved with 
the inhibition o the reaction. Further, 4-amino-
benzoate has no inhibitory affect on the activity of the 
enzyme and a slight activation is observed with this 
compound. This result supports the requirement of an 
hydroxyl group for inhibition to take place. 
Various other compounds that function as allosteric 
modifiers of other enzymes were also tested to determine 
if they were capable of influencing the catalytic act-
ivity of chorismate lyase. The results indicated that 
TABLE IX. Inhibition and Activation of Chorismate 
Lyase by Various Substrate and Product 
Analogues. 
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Addition Concentration Relative 
Activity 
None 
2,3-dihydroxybenzoic acid 
phenylalanine 
anthranilic acid 
tryptophan 
salicylic acid 
4-aminobenzoic acid 
tyrosine 
barium prephenate 
3,4-dihydroxybenzoic acid 
3-hydroxybenzoic acid 
3-(1'-carboxyvinyloxy) 
henzoic acid 
phenylacetic acid 
phenyllactic acid 
2,5-dihydroxybenzoic acid 
l.0mM 
1. 0mM 
0.lmM 
1. 0mM 
1. Oml'-1. 
1. 0mM 
l.0mM 
l,0mM 
l.0mM 
1. 0mM 
0.lmM 
0.0lmM 
1 .. 0mM 
l.0rnM 
l.0mM 
l.0mM 
0,lmM 
0.0lmM 
(%) 
100 
100 
114 
100 
100 
100 
100 
111 
112 
100 
4 
72 
91 
100 
80 
100 
100 
0 
100 
Compounds were added to the standard reaction mixture giving 
a final concentration as shown in the Table. Conditions for 
the assay of enzymic activity were the same as described in 
MATERIALS AND METHODS. Activity is expressed as a percent-
age of the activity of the enzyme with no additions. 
[ 
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fructose 1,6 diphosphate (1 mM), cyclic adenosine mono-
phosphate (1 mM) and adenosine triphosphate (1 mM) and 
MgC1 2 (10 mM) neither activated or inhibited the 
enzyme. 
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DISCUSSION 
As mentioned in Section 3.1, certain difficulties 
arise in the determination of the concentration of 
chorismate lyase in the cell. This aspect has therefore 
been i gnore d . However, since one of the primary aims of 
the wor k presented in this thesis was to determine if 
chorisma te lyas e posse ssed a high or low turnover number, 
the data has been calculated and presented in Table X. 
A comparison of other enzymes which convert chorismate 
as substrate has also been made. It is clear from the 
values obtained that chorismate mutase-prephenate 
dehydrogenase which is associated with the production of 
tyrosine, a ma jor biosynthetic product, possesses two 
large turnover numbers (of the order of one and three 
thousand). This enzyme is a bifunctional enzyme and the 
values obtained indicate the importance of the pathway. 
Similarly , chorismate mutase-prephenate dehydratase which 
is involved with the production of phenylalanine and is 
also a bifunctional enzyme has high turnover numbers for 
both activiti es (of the order of three and two thousand) . 
Anthranilate syn thetase which converts chorismate to 
anthranilate and so to tryptophan, has a turnover number 
considerably lowe r than the other two enzymes mentioned 
above (three hundred). However, this value is 
110. 
TABLE X. The Turnover Number for Enzymes from E. coli 
Associated with Chorismate 
Enzyme 
Chorismate lyase 
Anthranilate synthetasea 
Chorismate mutase-prephenate 
dehydrogenaseb 
1. mutase 
2. dehydrogenase 
Chorismate mutase-prephenate 
dehydratasec 
1. mutase 
2. dehydratase 
Turnover Number 
moles of substrate metabolized 
per min per catalytic unit 
6 76 
800 
2,700 
2,700 
1,200 
.06 
a) Data calculated from Baker and Crawford (1966) 
and Ito and Yanofsky (1969). 
b) Data calculated from Koch et al. (1971). 
c) Data calculated from Davidson et al. (1972). 
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high compared to the turnover number for chorismate 
lyase. This qumber, of .06 is very low and is not un-
expected because of (1) the role of 4-hydroxybenzoate in 
the cell's metabolism and (2) the pathway involved in the 
biosynthesis of ubiquinone is a minor one compared to 
the pathways involved in the production of the amino 
acids. 
With the identification and formulation of the 
reaction products in equimolar amounts and the isolation 
of a homogeneous protein, the enzyme chorismate lyase, 
was therefore suitable for mechanistic studies. The 
discussion of the possible mechanism of the reaction is 
limited to a discussion of qualitative data only because 
no inhibition by pyruvate was observed. 
Both steady-state kinetics and Michaelis kinetics 
assume that no inhibition is observed by the products or 
by the substrate. However, in discussing the possible 
mechanism of the reaction, steady-state kinetics is 
assumed, as it is the easier of the two to discuss when 
drawing conclusions about alternative mechanisms of the 
reaction. 
From the information obtained three possible mechan-
isms are proposed. The first mechanism shown below 
assumes steady-state kinetics and is ordered. 
1 12 . 
chorismate pyruvate 4-hydroxybenzoate 
E ( E-chorismate ) 
( E-4~hydroxy- ) 
· ( benzoate-pyruvate) 
(E-4..-hydroxy- ) 
( benzoate ) 
E 
Initially, in this mechanism chorismate binds guite strongly 
to the Enzyme. If an ordered mechanism exists, pyruvate 
must be released first from the Enzyme-chorismate complex, 
thus leaving the Enzyme-4~hydroxybenzoate complex. This 
complex dissociates very slowly as is indicated by the Ki 
for 4-hydroxybenzoate ,· (Ki = 0. 006 ± ·O. 002 rnM) • It thus 
competitively inhibits the reaction. It is also possible 
in a steady-state that the release of ·pyruvate could also 
be a slow step. However, regardless of whether the pyr uvate 
and/or the 4-hydroxybenzoate release is slow, the Enzyme~ 
chorismate complex is competively inhibited by the form-
ation of the Enzyme-4-hydroxybenzoate complex. This 
mechanism implies that the site on the Enzyme at which 
4-hydroxybenzoate inhibits is the same sit~ or very close 
to the site to which chorismate binds, as 4-hydroxy-
benzoate is a very effective inhibitor. If this were not 
so, then by altering the conformation of the protein 
slightly, the substrate would be able to b i nd as it does 
under normal conditions. 
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The second possible mechanism involves a random 
order of release of products. This is suggested by the 
fact that pyruvate does not inhibit the reaction. This 
reasoning may also be applied for the above mechanism. 
In the random order of release of products, the 
following pattern is observed. 
Py 4~hydroxybenzoate 
chorismate E-4-hydroxybenzoate } 
E E 
E_pyruvate 
4-hydroxybenzoate pyruvate 
This means that on the one hand pyruvate may be 
released first or on the other, 4-hydroxybenzoate may be 
released first. However, in the former case, the E-4-
hydroxybenzoate complex remains and this eventually will 
dissociate to form free enzyme and 4-hydroxybenzoate. 
In the latter case, 4-hydroxybenzoate is released from the 
complex initially. Thus in both cases 4-hydroxybenzoate is 
available to competitively inhibit the reaction. The one 
factor which must be considered in this mechanism, however, 
is that the breakdown of the enzyme substrate complex, to 
Enzyme-pyruvate-4-hydroxybenzoate, is the slow step. All 
other steps are fast and therefore permit this type of 
mechanism. 
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A third possible mechanism, similar to the firs 
mechanism but yet allows pyruvate not to inhibit, is shown 
below. 
chorismate 
J 
pyruvate 
E E-chorismate • E-4-hydroxybenzoate 
+ 
-pyruvate 
4-hydroxy-
benzoate 
t 
E-4-hydroxy-
benzoate 
E 
If the conversion of E-chorismate to E-4-hydroxybenzoate 
-pyruvate is slow, then the dissociation of the enzyme bound 
4-hydroxybenzoate must be rapid. This arises from the fact 
that if pyruvate were to inhibit, this complex would have 
to exist for some time in order to build up the concen-
tration to a reasonable level. 
These possible mechanisms are only able to be drawn 
from the data that has been obtained so far. However, 
more information is required about pyruvate in order to 
distinguish whether the machanism is ordered or random 
and which are the fast and slow steps in the dissociation 
of enzyme bound intermediates, 
SECTION 4. GENERAL DISCUSSION. 
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GENERAL DISCUSSION. 
It was indicated in Section 1 that chorismate is 
the branch-point compound of aromatic biosynthesis, and 
that the reaction discussed here is the first specific 
reaction involved in ubiquinone biosynthesis. In attempt-
ing to draw some conclusions about the possible role of 
chorismate lyase in the ubiquinone pathway and in more 
general terms, its relationship to the aromatic pathway , 
it must be remembered that ubiquinone is not a major 
product of aromatic bio-synthesis. This is in direct 
contrast to the amino acids. 
Chorismate lyase has been shown to be a single 
polypeptide chain, having a molecular weight of 15,800. 
Although the protein was shown to be homogeneous by 
sedimentation equilibrium experiments and by polyacryl-
amide gel electrophoresis in sodium dodecyl sulphate, 
ultracentrifugation analysis indicated that aggregates 
were probably formed at higher protein concentrations 
(at approximately 4 mg/ml). It is in fact not uncommon 
for proteins to exist as aggregates in the pure state, 
where these aggregates represent a state of lower 
energy. For example, Crestfield et al. (1962) have 
shown that bovine pancreatic ribonuclease A associates 
quite readily, but this phenomenon appears to be an 
16 . 
artifact of lyophilisation. Dimers and higher oligomers 
of ribonuclease A are formed, and although these are 
stable at 25°c, they rapidly dissociate at 65°c However, 
the specific activity of these aggregates i~ identical 
with he monomer. 
Margoliash and Lustgarten (1962) have also demon-
strated in st dies on cytochrome c that the dimer cryst-
allises together with the monomer. Among the proteins 
that are known to associate in the absence of disulphide 
links, may be found ribonuclease, cytochrome c, B-lacto-
globulin, lysozyme and glutamic acid dehydrogenase 
(Reithel, 1963). To establish the presence of aggregates 
of chorismate lyase unequivocally, further experimentation 
would be required. If aggregates are presen at lower 
protein concent ations, they are indistinguishable from 
the monomeric unit. This was indicated in t he kinetic 
experiments by the 1·nea relationship obtained with 
increasing protein concentrations up to 1 mg/ml. Above 
this concentration, further experimentation would be 
required to establish whether there is any departure from 
monomeric behaviour . 
The small size of chorismate lyase is not surprising, 
since more and more proteins are being isolated of similar 
size, which are nonetheless very eff icient at carrying 
out their catalytic function. It is interesting to 
compare chorismate lyase with ribonuclease of molecular 
weight 12,000 and lysozyme of molecular weight 13,900. 
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Both these proteins are small, but they do not lack 
efficiency or specificity in their catalytic function. 
Considering the regulation of enzymic reactions, 
it is often found that the end-product of a pathway reg-
ulates the first enzyme of the sequence. Where branched 
pathways are concerned, the 'branch-point' enzyme is 
usually repressed and this results in the pathway ceasing 
to function. With regard to chorismate lyase activity and 
the ubiquinone pathway, studies on the regulation of chor-
ismate lyase indicate that ubiquinone does not regulate 
the level of chorismate lyase. It was considered possible 
that other intermediates in the pathway could be respons-
ible for repressing the activity of the enzyme, and 
initial studies have shown that 2-octaprenylphenol or an 
earlier biosynthetic intermediate could be involved with 
the repression of the enzyme. Results from kinetic 
studies on chorismate lyase indicate that it is inhibited 
very strongly by the product of the first specific re-
action, 4-hyd~oxybenzoate~ Because of thts inhibition, 
the first reaction after the branch point compound, 
chorismate, ceases to operate well before the concentration 
of 4-hydroxybenzoate reaches 50 µM. 
The turnover number for chorismate lyase i8 . 06 which 
is extremely low, as would be expected for a reaction in a 
minor pathway. This would indicate that the concentration 
of 4-hydroxybenzoate in the cell would probably never 
reach 50 µM, since the rate of enzymic conversion is 
118. 
extremely low. It is important that rate of production 
of chorismate be sufficiently high at all times, as it is 
a branch-point compound, and is also required for the 
other major biosynthetic pathways. However, provided 
that the enzymic reactions in the pathway are well regu-
lated, then the rate of production of any compound will be 
equal to its rate of removal. 
Another approach to the regulation of chorismate 
lyase activity may possibly be connected with the second 
specific reaction in ubiquinone biosynthesis. This 
involves the enzyme 4-hydroxybenzoate octaprenyltrans-
ferase. The side chain precursor and the enzyme in this 
reaction are membrane bound (Young et al. 1972), unlike 
chorismate lyase which is soluble. However, a loose 
arrangement, or aggregate, could exist between chorismate 
lyase and 4-hydroxybenzoate octaprenyltransferase. This 
idea is based on the location of the two genes on the 
E.coli chromosome. Both the uhlC and ®iA genes map 
at approximately the same position and· the formation of a 
gene cluster (Section 2.1) may be advantageous to the 
cell. 
If a gene cluster for these reactions were to exist, 
one of the important advantages to the cell would be that 
an end-product of a chain of reactions could repress the 
synthesis of the two enzymes in the pathway. Secondly , 
if the gene products were extremely unstable their con~ 
current synthesis might require that the genes be very 
119. 
close together. Thirdly, if the genes were close together 
this would then enable the metabolic products of the 
reactions to be handled with ease. 
If an organisation, such as the above, were to 
exist in the cell, regulation of enzymic reactions would 
be much more efficient. For example, a high concentration 
of substrate in the immediate vicinity of the enzyme would 
not be required. Other complexes have been shown to occur 
in the aromatic pathway and one that occurs in the common 
pathway of N. crassa consists of five enzymes (Giles et al. 
1967). This complex catalyses the reactions from 3-deoxy-
D-arabino-heptulosonic acid 7-phosphate to 3-enolpyruvyl 
shikimate-5-phosphate (Figure 1.1). Burgoyne et al. 
(1969) have purified this a~om complex and estimated it 
to have a molecular weight of 231,000. 
During the isolation procedure there appeared to be 
no separation of the five enzymic activities. However, 
when the complex was dissociated into lower molecular 
weight species, a loss in all of the activities was ob~ 
served. The possible function of this ar~m gene cluster 
(or any other gene cluster) has been suggested by Giles 
et al. (1967) to facilitate the aggregation of biosyn-
thetic enzymes and as well to separate the synthetic from 
the degradative pathway in cases where the pathways are 
competitive. This could very well apply to biosynthetic 
pathways where a single compound, such as chorismate, 
could be channelled in numerous directions . Other 
complexes of enzymes have also been shown to occu r i n 
aromatic biosynthesis, e.g. Nester et al. (1967) have 
shown tha in B. subtilis, DAHP synthetase, shikimate 
kinase and chorismate mutase are physically associated. 
Another aggregate in N. crassa involved with tryptophan 
synthesis has been shown to contain three enzymes which 
behave as one homogeneous protein (Gaertner and DeMoss, 
1969). This involves the enzymes anthranilate synthet-
ase, N-(5'-phosphoribosyl)-anthranilate isomerase and 
glycerol phosphate synthetase. 
The presence of so many aggregates in aromatic 
biosynthesis favours the likelihood of chorismate lyase 
and 4-hydroxybenzoate octaprenyltransferase in E~ coli 
being able to form an aggregate. However, a detailed 
study on the biochemical properties of these two enzymes 
would be required to establish aggregate formation 8 
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